Introduction {#s1}
============

The dorsal-ventral axis is one of the earliest coordinate systems established during animal development and divides the embryo into dorsal (back) and ventral (belly) territories. This axis forms under the influence of the BMP/Chordin patterning system. The activator BMP induces the formation of ventral tissues, and BMP signaling is antagonized on the dorsal side by the inhibitor Chordin. There are currently several disparate models that can explain how BMP signaling is restricted to the ventral side ([@bib3]; [@bib2]; [@bib16]; [@bib6]; [@bib22]; [@bib41]; [@bib7]), but the underlying biophysical assumptions have not been fully tested.

In the 'Graded source-sink + mobile BMP model' (Model 1), BMP is produced in a graded, ventrally biased source, and signaling from diffusing BMP is antagonized by binding to its inhibitor Chordin ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). Chordin (Chd) diffuses from a localized source on the opposing dorsal side and therefore provides a 'sink' that inactivates BMP molecules diffusing through the embryo, helping to shape the signaling distribution into a gradient that peaks ventrally. The distributions of *bmp* and *chd* mRNA in developing embryos are consistent with this idea -- initially nearly uniform *bmp* expression refines to a ventrally biased gradient over time ([@bib41]; [@bib54]), and *chd* expression is restricted to the dorsal region ([@bib31]).
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###### Summary of model assumptions, predictions, and experimental findings.

Model assumptions or predictions that are consistent with the experimental findings (gray) are highlighted in green. NA: no testable model assumptions or predictions.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                             [Model 1]{.ul}\                                   [Model 2]{.ul}\                                   [Model 3]{.ul}\                              [Model 4]{.ul}\                                   [Model 5]{.ul}\                                   Experimental findings\
                                                             Graded source-sink (mobile BMP)\                  Graded source-sink (immobile BMP)                 Long-range accumulation and feedback         Self-regulating reaction-diffusion system         Shuttling\                                        \
                                                                                                                                                                                                                                                                \                                                 
  ---------------------------------------------------------- ------------------------------------------------- ------------------------------------------------- -------------------------------------------- ------------------------------------------------- ------------------------------------------------- -------------------------------------------------
  Diffusivity of BMP and Chordin                             *D*(BMP) \> 0\                                    *D*(BMP) ≈ 0\                                     *D*(BMP) ≈ *D*(Chd)\                         *D*(BMP) ≈ *D*(Chd)\                              *D*(BMP) \<\< *D*(Chd)                            *D*(BMP) ≤ *D*(Chd)\
                                                             *D*(BMP) \< *D*(Chd)                              *D*(Chd) high                                     High                                         Low                                                                                                 (≈2 and 6 µm^2^/s)

  Effect of Chordin on BMP diffusivity                       No effect                                         No effect                                         No effect                                    No effect                                         Chd enhances BMP diffusion                        No effect

  Half-life of BMP and Chordin                               *τ*(BMP) ≈ *τ*(Chd)                               Unconstrained                                     *τ*(BMP) \>\> *τ*(Chd)                       *τ*(BMP) ≈ *τ*(Chd)                               *τ*(BMP) \> *τ*(Chd)\*                            *τ*(BMP) ≈ *τ*(Chd)\
                                                                                                                                                                                                                                                                                                                  (130 and 120 min)

  pSmad gradient formation kinetics                          Progressive rise ventrally, always low dorsally   Progressive rise ventrally, always low dorsally   Initially high dorsally and ventrally        Progressive rise ventrally, always low dorsally   Progressive rise ventrally, always low dorsally   Progressive rise ventrally, always low dorsally

  Ventral pSmad peak decreased in the absence of Chordin?    No                                                No                                                No                                           No                                                Yes                                               No

  Dorso-lateral pSmad expansion in the absence of Chordin?   Yes                                               Yes                                               Yes                                          No                                                Yes                                               Yes

  Diffusivity of Sizzled relative to BMP/Chordin             NA                                                NA                                                *D*(ADMP) & *D*(Szl) ≈ *D*(BMP) & *D*(Chd)   *D*(ADMP) & *D*(Szl) \>\> *D*(BMP) & *D*(Chd)     NA                                                *D*(Szl) ≈ *D*(BMP) & *D*(Chd)\
                                                                                                                                                                                                                                                                                                                  (≈10, 2, and 6 µm^2^/s)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*The simplified shuttling model without ADMP presented here is based on the experimentally measured clearance rate constants of BMP and Chordin; the full model for scale-invariant patterning including ADMP ([@bib3]) assumes a lower stability of Chordin due to Xlr-mediated degradation.

Similar to Model 1, BMP signaling activity in the 'Graded source-sink + immobile BMP model' (Model 2, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}) is also restricted by the inhibitor Chordin diffusing from the dorsal side. However, Model 2 assumes that BMP does not diffuse ([@bib41]) and that it binds to Chordin with weaker affinity than in Model 1 (see Materials and methods). Proponents have argued that the similarities between the graded *bmp* mRNA distribution, signaling gradient, and target gene expression indicate negligible BMP diffusion during patterning ([@bib41]). Consistent with this, BMP4 was unable to induce long-range signaling in *Xenopus* experiments ([@bib23]), although BMP target genes are induced outside of BMP-expressing clones in zebrafish ([@bib52]). However, measuring the diffusivity of BMP *in vivo* is the most direct way to determine whether BMP is mobile ([@bib24]; [@bib54]).

Although these two relatively simple models are generally supported by biological observations, they do not take into account other regulators known to be crucial for dorsal-ventral patterning, such as the BMP-like ligand ADMP, and Sizzled, an inhibitor of the Chordin protease Tolloid/Xlr. Three models described below include these important dorsal-ventral regulators in addition to BMP and Chordin and have also been shown to explain scale-invariant patterning, a phenomenon in which embryos adjust their tissue proportions to differently sized patterning fields.

The recent 'Long-range accumulation and feedback model' (Model 3, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}) postulates that BMP and Chordin have equally high mobility, but that dorsal-ventral patterning is controlled by differences in BMP and Chordin protein stability ([@bib22]). In this model, BMP and ADMP induce the secreted, highly diffusible and stable Chordin protease inhibitor Sizzled. This protects Chordin from proteolysis and promotes its expansion towards the ventral side. Over time the resulting inhibition of BMP signaling leads to decreased Sizzled production, destabilizing Chordin and relieving inhibition of BMP. In this way, an appropriate balance between ventral BMP and dorsal Chordin levels can be established even in differently sized embryos.

In the 'Self-regulating reaction-diffusion model' (Model 4, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}), BMP and Chordin both have low diffusivities and equivalent protein stabilities. Interactions with highly mobile ADMP and Sizzled in two coupled reaction-diffusion networks eventually result in the restriction of BMP signaling activity on the ventral side, assuming an initial dorsal Chordin or ventral BMP bias ([@bib16]). Such a system self-regulates even with noisy initial conditions and could provide robustness during embryogenesis -- e.g., the ability of developing organisms to withstand noise in gene expression or fluctuating environmental conditions -- that can be difficult to explain with other models.

Finally, the prominent 'Shuttling model' (Model 5, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}) postulates that Chordin not only acts as an inhibitor of BMP, but also modulates the mobility and distribution of BMP protein ([@bib3]; [@bib2]; [@bib6]; [@bib7]). In this model, BMP is poorly diffusive, Chordin is highly diffusive, and BMP mobility increases when bound to Chordin. Cleavage of the BMP/Chordin complex by the uniformly distributed protease Tolloid/Xlr combined with a flux of Chordin from the dorsal side is thought to 'shuttle' BMP towards the ventral side by facilitated diffusion over time. In this way, Chordin is responsible for the accumulation of BMP protein on the ventral side, and actively helps establish the subsequent ventral BMP signaling peak.

These five conflicting models postulate different diffusion (no diffusion, equal diffusion, differential diffusion, facilitated diffusion) and stability properties of BMP and Chordin proteins ([Table 1](#table1){ref-type="table"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). However, these biophysical properties have not been fully measured experimentally, in part due to the lack of reagents and techniques to detect active BMP and Chordin in living vertebrate embryos. To test the biophysical tenets of these models, we developed active BMP and Chordin fluorescent fusion proteins, and used a combination of mathematical modeling and quantitative experiments to determine how BMP2b and Chordin gradients form. Additionally, we tested the distinct predictions that the five models make about how BMP signaling changes in the absence of Chordin. We found that (i) BMP2b and Chordin proteins have similar stabilities, (ii) both BMP2b and Chordin diffuse and form gradients in the extracellular space, and (iii) Chordin does not significantly facilitate BMP2b diffusion or play an active role in establishing peak ventral BMP signaling levels. Together, our results are most consistent with dorsal-ventral patterning mediated by Model 1, the 'Graded source-sink + mobile BMP' model.

Results {#s2}
=======

Chordin does not actively establish peak ventral BMP signaling {#s2-1}
--------------------------------------------------------------

BMP signaling induces phosphorylation and nuclear localization of the transcriptional effectors Smad1/5/9 ([@bib45]). To quantitatively measure BMP signaling activity during early dorsal-ventral patterning, we imaged pSmad1/5/9-immunostained zebrafish embryos fixed at different developmental stages using *in toto* light sheet microscopy, converted pSmad1/5/9 signaling activities into information-compressed two-dimensional maps ([@bib47]), and quantified pSmad1/5/9 intensities along the ventral-dorsal axis ([Figure 1A](#fig1){ref-type="fig"}, Materials and methods). Over the course of approximately 3 hr during early zebrafish development, BMP signaling rapidly shifts from a low-level near-uniform distribution to a gradient with peak levels on the ventral side ([Figure 1A+B](#fig1){ref-type="fig"}, [Videos 1](#video1){ref-type="video"}--[5](#video5){ref-type="video"}) ([@bib49]), similar to changes in the distribution of *bmp2b* mRNA over time ([@bib41]; [@bib54]). We simulated pSmad1/5/9 gradient formation kinetics predicted by each of the five models over a similar time period ([Figure 1C--G](#fig1){ref-type="fig"}). Our measurements are consistent with the gradient kinetics predicted by Models 1, 2, 4, and 5, whereas the dynamics predicted by Model 3 do not resemble the experimentally observed distributions.

![BMP signaling (pSmad1/5/9) gradient formation and simulations of five major dorsal-ventral patterning models over relevant zebrafish developmental stages (3 hr).\
(**A**) Two-dimensional Hammer-Aitoff projections (2D maps) of pSmad1/5/9-immunostained individual wild type zebrafish embryos at different developmental stages. Embryos were imaged using light sheet microscopy (see Materials and methods for details). (**B**) Quantification of ventral-to-dorsal average pSmad1/5/9 distributions in one-dimensional projections of 2D maps generated for embryos at different developmental stages (n = 3 for each stage) as in (**A**). Error bars denote standard error. (**C--G**) Gradient formation kinetics simulated for Models 1--5 at relevant zebrafish developmental stages.](elife-25861-fig1){#fig1}

###### 3D reconstruction of pSmad1/5/9 localization in a wild type sphere stage zebrafish embryo imaged by light sheet microscopy.

10.7554/eLife.25861.006

###### 3D reconstruction of pSmad1/5/9 localization in a wild type 30% epiboly stage zebrafish embryo imaged by light sheet microscopy.

10.7554/eLife.25861.007

###### 3D reconstruction of pSmad1/5/9 localization in a wild type 50% epiboly stage zebrafish embryo imaged by light sheet microscopy.

10.7554/eLife.25861.008

###### 3D reconstruction of pSmad1/5/9 localization in a wild type shield stage zebrafish embryo imaged by light sheet microscopy.

10.7554/eLife.25861.009

###### 3D reconstruction of pSmad1/5/9 localization in a wild type 60% epiboly stage zebrafish embryo imaged by light sheet microscopy.

10.7554/eLife.25861.010

All five major models of BMP/Chordin-mediated dorsal-ventral patterning qualitatively explain the formation of a ventral signaling peak, but they assign different roles to the inhibitor Chordin ([Figure 2A--E](#fig2){ref-type="fig"}, [Table 1](#table1){ref-type="table"}, and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Models 1 and 2 assume that a flux of the inhibitor Chordin from the dorsal side restricts the range of BMP signaling activity throughout the embryo. They thus predict that in the absence of Chordin, BMP signaling should be expanded throughout the embryo with a small increase in the peak levels on the ventral side ([Figure 2A+B](#fig2){ref-type="fig"}). Model 3 adds an additional regulatory layer: Here, the abundance of Chordin is regulated by feedback interactions that modify its stability and affect ventral BMP signaling levels ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Similar to Models 1 and 2, Model 3 also predicts that in the absence of Chordin, BMP signaling should be expanded throughout the embryo ([Figure 2C](#fig2){ref-type="fig"}).

![Theoretical predictions for the influence of the inhibitor Chordin on the BMP signaling gradient and experimental test.\
(**A--E**) Simulations of BMP distributions in five major models of dorsal-ventral patterning in the presence (black) or absence (red) of Chordin. The BMP and Chordin sources are indicated below each graph in green and blue, respectively. Note that the spatial production rates in Models 3 and 4 are modulated over time by feedback. (**F--G**) Quantification of average pSmad1/5/9 distributions in wild type (black) and *chordin^−/−^* (red) embryos using one-dimensional projections of 2D maps. Wild type n = 7, *chordin^−/−^* mutants n = 10. Error bars denote standard error. (**H**) p-values (unpaired two-tailed t-test assuming equal variance) calculated as a function of space between pSmad1/5/9 distributions in wild type and *chordin^−/−^* embryos shown in (**F**) indicate no significant difference of pSmad1/5/9 on the ventral side but a dramatic expansion into dorsal-lateral domains.](elife-25861-fig2){#fig2}

In Model 4, two reaction-diffusion systems involving BMP/Sizzled and Chordin/ADMP are coupled. In a completely homogenous field of cells with no initial expression biases, this self-organizing system would give rise to both ventral and dorsal BMP peaks ([@bib16]). To achieve a single ventral BMP peak, an initial dorsal Chordin or ventral BMP bias is required (see Materials and methods). Under these conditions, the initial advantage in BMP signaling on the ventral side is amplified by autoregulation of BMP production. Since Chordin inhibits the autoregulation of BMP production, the absence of Chordin leads to a more pronounced ventral BMP peak but has no effect in the rest of the embryo ([Figure 2D](#fig2){ref-type="fig"}). Model 4 thus predicts that in the absence of Chordin, pSmad1/5/9 levels would be increased on the ventral but not the dorsal side.

In contrast to Models 1--4, Model 5 assigns a more active role to Chordin in promoting the ventral BMP signaling peak. This model proposes that Chordin activity results in *increased* BMP signaling ventrally: Chordin increases ventral BMP levels by binding to and physically moving BMP protein towards the ventral side. This model therefore predicts that in embryos lacking Chordin, BMP signaling should be lower on the ventral side compared to wild type embryos ([Figure 2E](#fig2){ref-type="fig"}).

To experimentally test these predictions, we quantitatively measured BMP signaling activity in fixed *chordin^−/−^* zebrafish embryos ([Video 6](#video6){ref-type="video"}) and their wild type siblings using pSmad1/5/9 immunostaining and *in toto* light sheet microscopy. Strikingly, BMP signaling was increased in dorso-lateral domains in *chordin^−/−^* mutants compared to wild type embryos, but BMP signaling on the ventral side was not significantly affected ([Figure 2F--H](#fig2){ref-type="fig"}), consistent with the predictions from Models 1--3 and observations in *Xenopus* and zebrafish embryos ([@bib38]; [@bib54]), but not with the BMP signaling distributions predicted by Models 4 and 5 ([Table 1](#table1){ref-type="table"}).

###### 3D reconstruction of pSmad1/5/9 localization in a *chordin^−/−^* shield stage zebrafish embryo imaged by light sheet microscopy.

10.7554/eLife.25861.012

BMP and Chordin fluorescent fusion proteins diffuse and rapidly form gradients *in vivo* {#s2-2}
----------------------------------------------------------------------------------------

In order to understand the underlying basis of BMP/Chordin distribution and directly test the biophysical assumptions of the five dorsal-ventral patterning models, we developed fluorescent fusion proteins. We fused superfolder-GFP (sfGFP \[[@bib40]\]) and the photoconvertible protein Dendra2 ([@bib17]) to zebrafish Chordin and BMP2b, the major BMP ligand regulating zebrafish dorsal-ventral patterning ([@bib26]; [@bib52]). Basing our design on previously established fusions with small peptide tags ([@bib11]; [@bib12]; [@bib48]), we inserted fluorescent proteins to label the mature signaling domains, and obtained fusion proteins that are processed similarly and have similar biological activity as untagged versions or constructs fused to small FLAG tags ([Figure 3A--E](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Indeed, *BMP2b* mutants (*swr^−/−^*, which are normally severely dorsalized \[[@bib26]\]) can be rescued by injection of mRNA encoding BMP2b-Dendra2 or BMP2b-sfGFP at levels equivalent to untagged BMP2b ([Figure 3C](#fig3){ref-type="fig"}). In these experiments, the injected mRNA should be uniformly distributed, highlighting the important role of Chordin or other antagonists in shaping the graded BMP signaling distribution.

![Gradient formation kinetics of fluorescently tagged BMP and Chordin.\
(**A**) Schematic of BMP2b-sfGFP and -Dendra2 fusion constructs. (**B**) Fluorescent BMP2b fusion constructs can induce ventralization, a BMP-overexpression phenotype ([@bib26]). mRNA amounts equimolar to 2 pg of *BMP2b* mRNA were injected at the one-cell stage, and images were taken 30 hr post-fertilization (hpf). (**C**) Rescue of a *BMP2b* mutant (*swr^−/−^*) with BMP2b-Dendra2. 2.74 pg of BMP2b-Dendra2-encoding mRNA were injected at the one-cell stage, and images were taken at 30 hpf. In a separate experiment with 1 pg of BMP2b-sfGFP-encoding mRNA, 20% (9/44) of all injected *swr^−/−^* mutants were rescued, 16% (7/44) were ventralized, and 64% (28/44) were dorsalized. (**D**) Schematic of Chordin-sfGFP and -Dendra2 fusion constructs. (**E**) Fluorescent Chordin constructs can induce dorsalization, a *Chordin*-overexpression phenotype. mRNA amounts equimolar to 30 pg of *Chordin* mRNA were injected into wild type embryos at the one-cell stage, and images were taken at 30 hpf. F + G) Light sheet microscopy images of BMP- and Chordin-sfGFP gradients forming from a local source in live zebrafish embryos. Approximately 50--75 cells expressing *BMP2b-sfGFP* (**F**) or *Chordin-sfGFP* (**G**) were transplanted into host embryos at sphere stage (see Materials and methods for details). The images show gradient formation in single optical slices approximately 20 min after transplantation. H + I) Quantification of BMP2b-sfGFP (**H**) and Chordin-sfGFP (**I**) gradient formation kinetics from a local source (BMP2b-sfGFP: n = 8; Chordin-sfGFP: n = 5). Dashed lines indicate the distance at which the protein distributions drop to 50% of their maximal concentration 60 min post-transplantation.](elife-25861-fig3){#fig3}

To measure the kinetics of BMP and Chordin protein gradient formation, we expressed BMP2b-sfGFP and Chordin-sfGFP from local sources in wild type zebrafish embryos ([@bib34]) and imaged the distribution profiles over time using light sheet microscopy ([Figure 3F--I](#fig3){ref-type="fig"}). Importantly, in previous experiments it has been demonstrated that BMP2b clones generated in a similar manner can recapitulate BMP signaling comparable to that observed along the dorsal-ventral axis ([@bib52]). Strikingly, both BMP2b-sfGFP and Chordin-sfGFP are secreted and diffuse in the extracellular space ([Figure 3F+G](#fig3){ref-type="fig"}, [Videos 7+8](#video7){ref-type="video"}), in contrast to the proposal of Model 2 that only Chordin -- but not BMP -- diffuses ([@bib41]) ([Table 1](#table1){ref-type="table"}) and the absence of long-range BMP4 signaling in *Xenopus* ([@bib23]). Both BMP2b-sfGFP and Chordin-sfGFP rapidly establish concentration gradients over the course of one hour ([Figure 3H+I](#fig3){ref-type="fig"}), consistent with the rapid patterning of the dorsal-ventral axis during zebrafish development.

###### Gradient formation in a dome stage wild type embryo with a BMP2b-sfGFP clone.

Imaging started approximately 15 min post-transplantation. Interval between frames: 5 min.

10.7554/eLife.25861.016

###### Gradient formation in a dome stage wild type embryo with a Chordin-sfGFP clone.

Imaging started approximately 15 min post-transplantation. Interval between frames: 5 min.

10.7554/eLife.25861.017

BMP and Chordin fluorescent fusion proteins have similar stabilities *in vivo* {#s2-3}
------------------------------------------------------------------------------

The gradient formed by Chordin-sfGFP has a moderately longer range than the one formed by BMP2b-sfGFP. For example, 60 min post-transplantation the BMP2b-sfGFP signal drops to 50% of the maximal concentration at a distance of 30--40 µm, whereas the gradient formed by Chordin-sfGFP reaches 50% of its maximal concentration at a distance of 50--60 µm from the source boundary at this time point ([Figure 3H+I](#fig3){ref-type="fig"}). This suggests that stability or diffusivity might differ between these proteins ([@bib33]; [@bib35]). Importantly, Models 3 and 5 assume that BMP is more stable than Chordin, whereas the other models assume either similar or unconstrained stabilities ([Table 1](#table1){ref-type="table"}).

To distinguish between these possibilities, we first determined protein stability in living zebrafish embryos using a Fluorescence Decrease After Photoconversion (FDAP) assay ([@bib34]; [@bib8]; [@bib42]). We expressed BMP2b and Chordin fused to the green-to-red photoconvertible protein Dendra2 uniformly in zebrafish embryos, used brief UV exposure to convert the signal from green to red to generate a pulsed protein pool, and monitored the decrease in extracellular red fluorescence over time ([Figure 4A+B](#fig4){ref-type="fig"}). For BMP2b-Dendra2, we found a clearance rate constant of *k~1~* = (8.9 ± 0.1) × 10^−5^/s (half-life 130 min, [Figure 4A](#fig4){ref-type="fig"}). For Chordin-Dendra2, we measured a similar clearance rate constant of *k~1~* = (9.6 ± 0.3) × 10^−5^/s (half-life 120 min, [Figure 4B](#fig4){ref-type="fig"}). The similar clearance rate constants suggest that differential protein stabilities cannot account for the different protein distributions of BMP2b and Chordin. Importantly, these results are inconsistent with the differential protein stabilities predicted by Models 3 and 5 ([Table 1](#table1){ref-type="table"}).

![Biophysical measurements of BMP and Chordin protein stability and diffusivity.\
A + B) FDAP protein stability measurements for BMP2b-Dendra2 (**A**) and Chordin-Dendra2 (**B**). Error bars denote standard deviation. BMP2b-Dendra2: n = 22; Chordin-Dendra2: n = 6. C + D) FRAP effective protein diffusivity measurements for BMP2b-Dendra2 (**C**) and Chordin-Dendra2 (**D**). Data and fits from single experiments are shown. (**E**) Bar chart of the average effective diffusion coefficients from FRAP experiments. Error bars denote standard error. BMP2b-Dendra2: n = 6; BMP2b-sfGFP: n = 8; Chordin-Dendra2: n = 8; Chordin-sfGFP: n = 6; Sizzled-sfGFP: n = 12. (**F**) Free diffusion coefficients of BMP2b-sfGFP and Chordin-sfGFP measured by Fluorescence Correlation Spectroscopy (FCS) in a diffraction-limited spot within the zebrafish embryonic extracellular space far away from cell membranes (see Materials and methods for details). Error bars denote standard error. BMP2b-sfGFP: n = 17 measurements from 4 embryos; Chordin-sfGFP: n = 19 measurements from 5 embryos. (**G**) Negligible influence of Chordin on BMP2b effective diffusion. Untagged Chordin was co-expressed with BMP2b-Dendra2 (n = 8) or BMP2b-sfGFP (n = 9) in zebrafish embryos subjected to FRAP measurements at blastula stages. The data shown for BMP2b-Dendra2 and BMP2b-sfGFP FRAP experiments without co-expressed *Chordin* is identical to the data shown in (**E**). p-values (unpaired two-tailed t-test assuming equal variance) are shown for statistically significant (p\<0.05) data sets.](elife-25861-fig4){#fig4}

Diffusivity of BMP and Chordin fluorescent fusion proteins *in vivo* {#s2-4}
--------------------------------------------------------------------

Our finding that BMP2b- and Chordin-Dendra2 fusions have similar stabilities ([Figure 4A+B](#fig4){ref-type="fig"}) suggests that differences in diffusivity could account for the slight differences in gradient formation kinetics. Indeed, when we fitted a gradient formation model based on local production, uniform diffusion, and clearance constrained with our measured protein half-lives in a realistic three-dimensional zebrafish embryo-like geometry ([@bib34]) to the measured protein distributions, we obtained the best agreement between model and data with lower diffusivity of BMP2b (4 µm^2^/s) compared to Chordin (6 µm^2^/s) ([Figure 3---figure supplement 2A+B](#fig3s2){ref-type="fig"}).

Importantly, the five models assume distinct BMP and Chordin diffusion properties ([Table 1](#table1){ref-type="table"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), from no BMP diffusion (Model 2) to substantially higher Chordin mobility compared to BMP (Model 5). To directly test these predictions, we determined the effective diffusivities of fluorescently tagged BMP2b and Chordin moving through developing zebrafish embryos. We used a Fluorescence Recovery After Photobleaching (FRAP) assay ([@bib34]) that measures the dynamics of re-appearance of fluorescence in a bleached region in embryos uniformly expressing fluorescent fusion proteins ([Figure 4C--E](#fig4){ref-type="fig"}). We found effective diffusion coefficients of 2--3 µm^2^/s for BMPs (BMP2b-Dendra2: 2.0 ± 0.4 µm^2^/s; BMP2b-sfGFP: 2.6 ± 0.7 µm^2^/s (similar to \[[@bib54]\]) and of 6--7 µm^2^/s for Chordin (Chordin-Dendra2: 6.0 ± 0.7 µm^2^/s; Chordin-sfGFP: 7.3 ± 3.9 µm^2^/s), indicating that slight differences in diffusivities could underlie the differences in protein distributions. This idea is further supported by the agreement between gradients simulated with the measured diffusivities and clearance rate constants and our experimentally determined protein gradients ([Figure 3---figure supplement 2E--H](#fig3s2){ref-type="fig"}). The measured diffusion coefficients are most consistent with Models 1 and 4, which assume either similarly low diffusivities (Model 4) or that BMP has a moderately lower diffusion coefficient than Chordin (Model 1, [Table 1](#table1){ref-type="table"}). As observed in the BMP2b-sfGFP gradient formation experiment ([Figure 3F--I](#fig3){ref-type="fig"}), our FRAP data demonstrate that BMP2b-sfGFP is mobile *in vivo*, inconsistent with Model 2.

Strikingly, local diffusion measurements in very small extracellular volumes far away from cell surfaces using Fluorescence Correlation Spectroscopy (FCS) assays showed that BMP2b-sfGFP (free diffusion coefficient: *D~f~* = 46 ± 1 µm^2^/s) and Chordin-sfGFP (free diffusion coefficient: *D~f~* = 59 ± 2 µm^2^/s) are highly mobile over short spatial and temporal scales ([Figure 4F](#fig4){ref-type="fig"}), whereas their diffusivities are reduced at the global scale when they move across a field of cells ([Figure 4E](#fig4){ref-type="fig"}). We hypothesize that the difference between effective diffusivities (measured by FRAP) and local diffusivities (measured by FCS) is due to binding to immobile extracellular molecules, which could serve as diffusion regulators that hinder the mobility of BMP2b and Chordin, similar to what has been proposed for other developmental signals such as Nodal and FGF ([@bib34]; [@bib35]).

Sizzled, BMP, and Chordin diffusivities are within the same order of magnitude {#s2-5}
------------------------------------------------------------------------------

Models 3 and 4 assign important roles to the secreted proteins ADMP and Sizzled in regulating BMP signaling and distribution. Model 3 postulates diffusivities of ADMP and Sizzled equivalent to BMP and Chordin, whereas Model 4 requires approximately 25-fold higher diffusivities of ADMP and Sizzled compared to BMP and Chordin ([Table 1](#table1){ref-type="table"}). To measure the diffusivities of ADMP and Sizzled and test these assumptions, we developed fluorescent ADMP and Sizzled fusion proteins (see Materials and methods). Whereas Sizzled fusion proteins had activity comparable to untagged Sizzled ([Figure 4---figure supplement 1A--C](#fig4s1){ref-type="fig"}), ADMP fusions with sfGFP or FLAG tags inserted 2, 5, or 11 amino acids after the Furin cleavage site were much less active than untagged ADMP (data not shown), and could therefore not be used for diffusion measurements. Using FRAP, we measured an effective diffusion coefficient of 9.7 ± 3.2 µm^2^/s for Sizzled-sfGFP ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). This measurement is consistent with Model 3, but not Model 4, the latter of which requires much higher Sizzled mobility ([Table 1](#table1){ref-type="table"}).

When parameterized with these measured diffusion coefficients and over a \~100-fold range of ADMP diffusion coefficients, Model 3 can form ventral-dorsal gradients over relevant time scales ([Figure 4---figure supplement 1F--J](#fig4s1){ref-type="fig"}), but the kinetics of gradient formation do not reflect the measurements of pSmad1/5/9 distribution profiles in [Figure 1A+B](#fig1){ref-type="fig"}. Moreover, the relatively minor difference between BMP/Chordin and Sizzled diffusivity is not compatible with the 25-fold differential required for Model 4 ([Figure 4---figure supplement 1K--P](#fig4s1){ref-type="fig"}).

Chordin does not regulate BMP protein diffusivity or distribution {#s2-6}
-----------------------------------------------------------------

Model 5 (Shuttling) postulates that highly diffusive Chordin enhances the mobility of poorly diffusive BMPs ([@bib3]). In this model, Chordin is secreted dorsally, binds to relatively immobile BMP, and creates a highly mobile BMP/Chordin complex. This complex then diffuses until Chordin is cleaved by a protease (Xlr), rendering BMP immobile again ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). To investigate whether Chordin is not only an inhibitor of BMP, but also enhances BMP diffusivity, we increased Chordin levels and measured the effective diffusivity of fluorescent BMP2b. In embryos overexpressing Chordin, we did not observe a significant change in the effective diffusivity of fluorescently tagged BMP2b compared to embryos that did not overexpress Chordin (BMP2b-Dendra2 + Chordin: 2.2 ± 0.2 µm^2^/s; BMP2b-sfGFP + Chordin: 2.8 ± 0.7 µm^2^/s; [Figure 4G](#fig4){ref-type="fig"}). The ability of Chordin to enhance the diffusivity of BMP, a major tenet of Model 5, is therefore not supported by FRAP data.

Model 5 also predicts that Chordin alters the distribution of BMP protein. Over time, the shuttling of BMP by Chordin causes BMP to accumulate away from the Chordin source, resulting in an opposing peak of BMP. Our observation that Chordin does not affect the diffusivity of BMP challenges this view ([Figure 4G](#fig4){ref-type="fig"}). However, to directly test whether a Chordin source can alter BMP distribution ([Figure 5A+B](#fig5){ref-type="fig"}), we juxtaposed clones of BMP2b-sfGFP-producing cells with clones of cells secreting untagged Chordin and imaged the formation of the BMP2b-sfGFP gradient over time using light sheet fluorescence microscopy ([Figure 5C+D](#fig5){ref-type="fig"}, [Videos 9](#video9){ref-type="video"}--[10](#video10){ref-type="video"}). Model 5 predicts a steeper BMP2b-sfGFP gradient in the presence of an adjacent Chordin-producing clone compared to a wild type clone ([Figure 5A+B](#fig5){ref-type="fig"}). Although BMP2b-sfGFP gradients tend to be slightly steeper in the presence of a neighboring Chordin-expressing clone compared to a non-Chordin-expressing clone ([Figure 5D](#fig5){ref-type="fig"}), this minor change is unlikely to account for the formation of a ventral peak in BMP signaling during the short time (hours) required to complete dorsal-ventral patterning ([Figure 1A+B](#fig1){ref-type="fig"}). We also failed to observe significant redistribution of BMP in simulations of adjacent BMP and Chordin clones using our measured diffusion coefficients and half-lives ([Figure 5E+F](#fig5){ref-type="fig"}). This suggests that shuttling of BMP2b by Chordin is not relevant for the early aspects of dorsal-ventral patterning in zebrafish embryos.

![Testing shuttling of BMP2b predicted by Model 5.\
(**A**) One-dimensional model of two clones expressing BMP (green) or Chordin (blue) with *D~BMP~* = 2 μm^2^/s, *D~Chd~* = 100 μm^2^/s, and *D~ChdBMP~* = 100 μm^2^/s. BMP levels increase over time due to constant production. In the presence of Chordin, the BMP gradient is deflected away from the Chordin source indicative of shuttling (compare black and red lines). Solid lines show total BMP levels (i.e. BMP + ChdBMP in the presence of Chordin), and dashed line shows free BMP levels. (**B**) BMP gradients to the right of the BMP-expressing clone re-normalized to the BMP concentration at the source boundary to demonstrate that the range of BMP is decreased between the two clones in the presence of Chordin. The main panel shows total BMP levels (i.e., BMP + ChdBMP in the presence of Chordin), and the inset shows free BMP levels (dashed lines). (**C**) Experimental test of the predictions in (**A**) and (**B**). Clones of cells expressing BMP2b-sfGFP (green) were generated by transplanting approximately 50--75 cells from a donor embryo into wild type hosts at sphere stage (see Materials and methods for details). Another clone of cells (red) was transplanted next to the BMP2b-sfGFP-expressing clone shortly after. The red clone is marked by the presence of fluorescent Alexa 546-coupled dextran. Cells from red-labeled clones either contained only Alexa 546-coupled dextran ([Video 9](#video9){ref-type="video"}) or Alexa-546-coupled dextran and ectopic *chordin* mRNA ([Video 10](#video10){ref-type="video"}). 15--20 min after transplantation of the clones, embryos were imaged using light sheet microscopy. The image shows gradient formation in a single optical slice approximately 20 min after transplantation. (**D**) Quantification of average BMP2b-sfGFP gradients at \~15 min or \~75 min after transplantation in embryos generated as in (**C**) with (red/brown) or without (black/gray) ectopic Chordin sources. Error bars denote standard error. n = 8 for each condition. (**E**) One-dimensional simulation of two clones expressing BMP (green) or Chordin (blue) with the experimentally measured diffusion coefficients *D~BMP~* = 2 μm^2^/s, *D~Chd~* = 6 μm^2^/s, and *D~ChdBMP~* = 2.2 μm^2^/s. BMP levels increase over time due to constant production. Solid lines show total BMP levels (i.e. BMP + ChdBMP in the presence of Chordin), and the dashed line shows free BMP levels. Only the distribution of free BMP is affected as a consequence of Chordin binding, and the gradient of total BMP is not deflected away from the Chordin source (compare solid black and red lines). (**F**) Gradients of total BMP levels to the right of the BMP expressing clone simulated with the experimentally measured diffusion coefficients (*D~BMP~* = 2 μm^2^/s, *D~Chd~* = 6 μm^2^/s, and *D~ChdBMP~* = 2.2 μm^2^/s) and renormalized to the concentration at the boundary show that the range of BMP is not decreased between the two clones in the presence of Chordin.](elife-25861-fig5){#fig5}

###### Gradient formation in three representative dome stage wild type embryos with BMP2b-sfGFP clones (green) next to clones labeled with Alexa 546-coupled dextran (red).

Imaging started approximately 15 min post-transplantation. Interval between frames: 5 min. The video shows images that were normalized to the mean intensity of a region close to the BMP2b-sfGFP source boundary in each embryo at the first time point. 

10.7554/eLife.25861.021

###### Gradient formation in three representative dome stage wild type embryos with BMP2b-sfGFP clones (green) next to *chordin*-expressing clones labeled with Alexa 546-coupled dextran (red).

Imaging started approximately 15 min post-transplantation. Interval between frames: 5 min. The video shows images that were normalized to the mean intensity of a region close to the BMP2b-sfGFP source boundary in each embryo at the first time point.

10.7554/eLife.25861.022

Discussion {#s3}
==========

The BMP signaling gradient patterns the dorsal-ventral axis during animal development. Five major models can explain how a ventral peak of BMP signaling forms, but the biophysical assumptions underlying these models differ widely ([Table 1](#table1){ref-type="table"}). After experimentally examining these assumptions, our findings lead to four main conclusions. First, Chordin does not play an active role in generating BMP signaling peaks, but only globally inhibits BMP ([Figure 2](#fig2){ref-type="fig"}). This is consistent with graded source-sink-type models (e.g. Models 1 and 2) and Model 3, but inconsistent with Models 4 and 5 ([Table 1](#table1){ref-type="table"}). Interestingly, BMP signaling in the absence of Chordin is not raised on the extreme dorsal side, indicating that other extracellular inhibitors such as Follistatin or Noggin ([@bib50]) or inhibitors of *bmp* expression ([@bib27]; [@bib29]; [@bib41]) that were not included in the tested models might further restrict BMP signaling in these regions. Second, BMP2b and Chordin both diffuse in the extracellular space ([Figure 3F--I](#fig3){ref-type="fig"}), challenging models involving immobile BMP (Model 2). Third, fluorescently tagged BMP2b and Chordin have similarly high local diffusivities ([Figure 4F](#fig4){ref-type="fig"}), but on a global scale they move much more slowly through the embryo ([Figure 4E](#fig4){ref-type="fig"}). These findings rule out Models 2, 3, and 5, but are consistent with Models 1 and 4. Fourth, Chordin does not significantly affect BMP2b diffusion or protein distribution in zebrafish embryos ([Figure 4G](#fig4){ref-type="fig"}, [Figure 5](#fig5){ref-type="fig"}), undermining shuttling models in this developmental context. Instead, our data are most consistent with Model 1, the graded source-sink model of BMP/Chordin-mediated dorsal-ventral patterning during early zebrafish development. Our conclusions are also consistent with a recent complementary study ([@bib54]).

Notably, shuttling models (e.g. Model 5) have gained prominence in many developmental contexts including scale-invariant patterning ([@bib3]; [@bib2]; [@bib16]; [@bib37]; [@bib4]; [@bib5]; [@bib20]), but the fundamental tenet, that is, whether putative shuttles such as Chordin change the diffusivity and distribution of signals such as BMP, has not been directly examined. Alternative models that do not invoke Chordin-dependent facilitated BMP diffusion (Model 4) ([@bib16]) or that postulate differential protein stability (Model 3) ([@bib22]) can also explain scale-invariant patterning. Our data do not provide strong evidence for shuttling of BMP2b at time scales relevant for dorsal-ventral patterning during early zebrafish embryogenesis: We failed to observe a significant modulation of BMP2b-sfGFP or BMP2b-Dendra2 diffusivity or distribution by Chordin ([Figure 4G](#fig4){ref-type="fig"}, [Figure 5](#fig5){ref-type="fig"}). It is, however, possible that other BMPs (e.g. BMP4, BMP7, ADMP) are shuttled by interactions with Chordin and its protease Tolloid/Xlr. Indeed, *tolloid* mutants display a mild patterning defect of the ventral tail fin ([@bib10]) that might reflect a requirement for the ventral accumulation of a weakly active, dorsally expressed BMP ligand such as ADMP ([@bib13]; [@bib28]).

The graded source-sink model (Model 1) that is best supported by our data describes a system in which the graded, ventrally biased distribution of *bmp* mRNA and the dorsally localized *chd* mRNA distribution produce opposing sources of extracellular, diffusing BMP and Chordin protein, which together generate the BMP signaling gradient required for proper dorsal-ventral patterning. Notably, this model fails to take other known dorsal-ventral regulators into account (e.g., ADMP, Sizzled, Follistatin, Noggin). Furthermore, approximately one third of *bmp2b* and *chordin* mutant embryos can be rescued by apparently uniform *bmp* and *chordin* expression, respectively ([@bib26]; [@bib15]) ([Figure 3C](#fig3){ref-type="fig"}), arguing against a strong requirement for concurrent opposing BMP and Chordin sources as long as one component of the system is biased (i.e. ventrally biased *bmp2b* expression with uniform Chordin, or dorsally biased *chordin* expression with uniform BMP). Thus, further adjustments to the basic Model 1 will be required to fully describe dorsal-ventral patterning.

Although our results support a role for BMP diffusion in dorsal-ventral patterning, the necessity of signal diffusion for developmental patterning has recently been challenged by several studies ([@bib9]; [@bib43]; [@bib1]; [@bib14]; [@bib51]). It will be interesting to determine whether BMP diffusion is indeed required for proper patterning using emerging nanobody-mediated diffusion perturbations ([@bib19]) or optogenetics-based cell-autonomous modulation of signaling range ([@bib44]).

Materials and methods {#s4}
=====================

Immunostainings {#s4-1}
---------------

To visualize pSmad1/5/9, wild type TE embryos were dechorionated at the one-cell stage using 1 mg/ml of Pronase (Roche, Cat. No. 11 459 643 001). Dechorionated embryos were incubated at 28°C and fixed at different developmental stages in 4% formaldehyde (Roth) in PBS overnight at 4°C on a shaker. Embryos were then stored in 100% methanol at −20°C for at least 2 hr. All subsequent steps were carried out at room temperature. Embryos were re-hydrated with 70%, 50%, and 30% methanol in PBS for 10 min each. The embryos were then washed eight times with PBST (0.1% Tween) for 15 min and blocked twice with blocking solution (10% fetal bovine serum and 1% DMSO in PBST) for 1 hr, and incubated with 1:100 anti-pSmad1/5/9 antibody (Cell Signaling Technology, Cat. No. 9511) for 4 hr. Embryos were washed with blocking solution for 15 min, washed seven times with PBST, blocked with blocking solution for 1 hr, incubated with 1:500 Alexa 488-coupled goat anti-rabbit secondary antibody (Life Technologies, Cat. No. A11008) for 4 hr, and washed similarly to the procedure after primary antibody application. Embryos were then counterstained with DAPI solution (0.2 µg/ml in PBST) for 1 hr and washed with PBST. Immunostainings were performed using an In situ Pro hybridization robot (Abimed/Intavis).

To analyze pSmad1/5/9 distributions in the absence of Chordin, embryos from one pair of *chordin^tt250^* ([@bib18]) heterozygous parents were collected, fixed, immunostained with anti-pSmad1/5/9 antibody (Cell Signaling Technology, Cat. No. 13820S) as above, and imaged simultaneously to minimize differences between samples. Embryos were treated as described above, except that progeny from *chordin^+/- ^*incrosses were first permeabilized with ice-cold acetone at −20°C for 7 min before the re-hydration step. After imaging and DNA extraction ([@bib30]), progeny from the *chordin^tt250^* heterozygote incross were identified as wild type, heterozygous, or homozygous mutant embryos by PCR amplification using the forward primer 5'-TTCGTTTGGAGGACAACTCG-3' and the reverse primer 5'-AACTCAGCAGCAGAAGTCAATTC-3' with an initial denaturation step of 94°C for 3 min; 39 cycles of 94°C for 30 s, 55°C for 40 s, and 72°C for 30 s; and a final extension at 72°C for 5 min with subsequent digestion with MspI (New England Biolabs, Cat. No. R0106) for 2 hr. The genotyping assay for the *chordin^tt250^* line was designed by the Zebrafish International Resource Center (ZIRC) staff and downloaded from the ZIRC website at <http://zebrafish.org.>

Generation of fluorescent BMP2b fusions {#s4-2}
---------------------------------------

All constructs were generated by PCR-based methods ([@bib21]), contain the consensus Kozak sequence *gccacc* 5' of the start codon, and were inserted into the EcoRI and XhoI sites of the pCS2(+) vector. To generate BMP2b-sfGFP and BMP2b-Dendra2, sequences encoding sfGFP or Dendra2 flanked by LGDPPVAT linkers were inserted two amino acids downstream of the BMP2b Furin cleavage site. Sequences encoding the FLAG tag DYKDDDDK were inserted between the first linker and sfGFP or Dendra2 to generate BMP2b-sfGFP-FLAG and BMP2b-Dendra2-FLAG. To generate BMP2b-FLAG, the FLAG tag was inserted between two LGDPPVAT linkers two amino acids downstream of the BMP2b Furin cleavage site.

Generation of fluorescent Chordin fusions {#s4-3}
-----------------------------------------

All constructs were generated by PCR-based methods ([@bib21]) and contain the consensus Kozak sequence *gccacc* 5' of the start codon. Chordin was inserted into the ClaI site of pCS2(+). All other Chordin-containing constructs were inserted into the EcoRI and XbaI sites of the pCS2(+) vector. To generate Chordin-sfGFP and BMP2b-Dendra2, sequences encoding sfGFP or Dendra2 flanked by LGDPPVAT linkers were inserted immediately 5' of the Tolloid cleavage site 2. To generate Chordin-FLAG, sequences encoding the FLAG tag DYKDDDDK were inserted immediately 5' of the Tolloid cleavage site 2 without additional linkers. To generate Chordin-sfGFP-FLAG and Chordin-Dendra2-FLAG, sequences encoding the FLAG tag were inserted between the first linker and sfGFP or Dendra2 of Chordin-sfGFP and Chordin-Dendra2 constructs.

Generation of fluorescent Sizzled fusions {#s4-4}
-----------------------------------------

All Sizzled constructs were generated by PCR-based methods ([@bib21]), contain the consensus Kozak sequence *gccacc* 5' of the start codon, and were inserted into the EcoRI and XbaI sites of the pCS2(+) vector. To generate Sizzled-sfGFP, sequences encoding sfGFP with an N-terminal LGLG linker were fused to the C-terminus of Sizzled. Sequences encoding the FLAG tag DYKDDDDK were inserted between the LGLG linker and sfGFP to generate Sizzled-sfGFP-FLAG. To generate Sizzled-FLAG, the FLAG tag was fused to the C-terminus of Sizzled separated by an LGLG linker.

mRNA *in vitro* synthesis {#s4-5}
-------------------------

mRNA was generated using SP6 mMessage mMachine kits (Thermo Fisher) after vector linearization with NotI-HF (New England Biolabs, Cat. No. R3189). mRNA was purified using LiCl precipitation or Qiagen RNeasy kits following the manufacturers' instructions.

Phenotypic analysis {#s4-6}
-------------------

Scoring of ventralization and dorsalization was executed as previously described ([@bib32]; [@bib26]). Embryos were injected at the one- to two-cell stage with equimolar amounts of *BMP2b* (1 pg), *BMP2b-sfGFP* (1.49 pg), and *BMP2b-Dendra2* (1.47 pg) mRNA to assess ventralizing activity. At 1 day post-fertilization, BMP2b-injected embryos were classified as weakly ventralized (V1) to strongly ventralized (V4). V1 embryos have reduced eyes but a prominent head. V2 embryos have no eyes, reduction of the head, and expansion of posterior structures such as somites and tail. V3 embryos completely lack head structures and exhibit a further expanded tail and enlarged blood islands. Finally, V4 embryos lack most structures except for a short, protruding, and expanded tail.

To assess dorsalizing activity of the Chordin constructs, embryos were injected with equimolar amounts of *Chordin* (30 pg), *Chordin-sfGFP* (37 pg), *Chordin-Dendra2* (37 pg), and *Chordin-FLAG* mRNA (30 pg). Embryos were scored at 1 day post-fertilization and classified as weakly dorsalized (C1) to strongly dorsalized (C5) ([@bib26]). C1 embryos lack the ventral tail fin. C2 embryos have a further loss of ventral structures, such as the ventral tail vein, and a bent tail. C3 embryos exhibit a tail that is shortened and twisted. C4 embryos have observable head structures and develop eyes with twisting of the posterior structures above the yolk. C5 embryos are fully dorsalized and frequently lyse ([@bib32]; [@bib26]).

Rescue of *BMP2b* (*swr*^−/−^) mutants {#s4-7}
--------------------------------------

Injection of *BMP2b* mRNA can rescue *BMP2b* mutants ([@bib26]). To investigate whether tagged BMP2b constructs can rescue *swr^tc300−/−^* mutants ([@bib32]), the rescuing amount of *BMP2b* mRNA was first determined (1.8 pg), and equimolar amounts of mRNA encoding fluorescent fusion constructs were subsequently injected into the progeny of heterozygous *swr^+/- ^*mutant incrosses. Embryos with wild type morphology at 24 hpf were anesthetized and mounted in 2% methylcellulose for imaging with an AxioZoom V16 (ZEISS) microscope at 30--33 hpf. To genotype embryos following DNA extraction ([@bib30]), PCR was performed to amplify a BMP2b fragment with the forward primer 5\'-AAAAGCCGAGGAGAAAGCAC-3\' and the reverse primer 5\'-AGTCCTTCATTGGGGAGATTGTTC-3\', and the following thermocycling parameters: An initial denaturation step of 94°C for 3 min; 39 cycles of 94°C for 30 s, 58°C for 40 s, and 72°C for 40 s; and a final extension at 72°C for 5 min. PCR amplicons were subsequently digested with HaeIII (New England Biolabs, Cat. No. R0108) at 37°C for 2 hr. The genotyping assay for the *swr^tc300^* line was designed by the Zebrafish International Resource Center (ZIRC) staff and downloaded from the ZIRC website at <http://zebrafish.org>.

Preparation of extracellularly enriched fractions for western blotting {#s4-8}
----------------------------------------------------------------------

Extracellularly enriched and cellular fractions from manually deyolked embryos between sphere and dome stage were obtained as described previously ([@bib34]). mRNAs encoding FLAG-tagged constructs were injected at the one- or two-cell stage at equimolar amounts (*BMP2b-FLAG*: 444 pg, *BMP2b-sfGFP-FLAG*: 638 pg, *BMP2b-Dendra2-FLAG*: 630 pg; and *Chordin-FLAG*: 500 pg, *Chordin-sfGFP-FLAG*: 620 pg, *Chordin-Dendra2-FLAG*: 615 pg). For protein samples with BMP2b constructs, fractions from approximately 19 embryos were loaded and resolved by SDS-PAGE using 12% polyacrylamide gels. For protein samples with Chordin constructs, fractions from approximately 17--18 embryos were loaded and resolved in 8% polyacrylamide gels. Proteins were subsequently transferred onto PVDF membranes using a Trans-Blot Turbo Transfer System (Bio-Rad, Cat. No. 170--4272). Membranes were blocked with 5% non-fat milk (Roth, Cat. No. T145.2) in PBST (0.1% Tween) and incubated with anti-FLAG antibody (Sigma, Cat. No. F3165) at a concentration of 1:2000 in non-fat milk in PBST at 4°C overnight. HRP-coupled donkey anti-mouse secondary antibody (Jackson ImmunoResearch, Cat. No. 715-035-150) was used at concentration of 1:25,000 for 3 hr at room temperature. Chemiluminescence was detected using SuperSignal West Dura Extended Duration Substrate (Thermo Fisher, Cat. No. 34075) and imaged with a chemiluminescence imaging system (Fusion Solo, Vilber Lourmat).

Transplantations {#s4-9}
----------------

To generate clonal sources secreting BMP2b-sfGFP, Chordin-sfGFP, and untagged Chordin ([Figures 3](#fig3){ref-type="fig"} and [5](#fig5){ref-type="fig"}), approximately 50--75 cells were transplanted from sphere stage wild type TE donor embryos expressing these constructs into uninjected, sphere stage sibling hosts (similar to \[[@bib34]\]). Transplantations were carried out in 1 x Ringer's buffer. Cells were explanted from donors, extruded briefly into the buffer to wash away cellular debris and extracellular fluorescent protein, and then transplanted into host embryos.

Donor embryos were dechorionated with 1 mg/ml Pronase (Roche, Cat. No. 11 459 643 001) and injected with 1--2 nl injection mix at the one-cell stage. Sibling host embryos were dechorionated together with donors at the one-cell stage, and all embryos were incubated at 28°C until transplantation. Unfertilized or injured embryos were discarded.

For single ([Figure 3](#fig3){ref-type="fig"}) and double ([Figure 5](#fig5){ref-type="fig"}) transplantation experiments, BMP2b-sfGFP and Chordin-sfGFP donors were injected with 500 pg mRNA ([Figure 3---figure supplement 1F--H](#fig3s1){ref-type="fig"}).

For double transplantation experiments ([Figure 5](#fig5){ref-type="fig"}), embryos received one transplantation from a donor expressing BMP2b-sfGFP and a second transplantation from a donor injected at the one-cell stage with either 50 pg Alexa 546-coupled dextran (10 kDa, Molecular Probes, Cat. No. D22911) or 1000 pg Chordin mRNA + 50 pg Alexa 546-coupled dextran. Alexa 546-coupled dextran was used to mark the location of the second clone.

2--10 min post-transplantation, embryos were mounted in 1% low-melting NuSieve GTG agarose (Lonza, Cat. No. 50080) dissolved in embryo medium (250 mg/l Instant Ocean salt dissolved in reverse osmosis water). Embryos were immersed in 40°C molten low melting point agarose, pulled into 1.5 mm glass capillary tubes (ZEISS), and positioned with the animal pole perpendicular to the capillary using a metal probe. Agarose tubes were then suspended in embryo medium, and imaged at room temperature using a ZEISS Lightsheet Z.1 microscope (see *Light sheet microscopy* section for further imaging details).

Light sheet microscopy {#s4-10}
----------------------

Fluorescence images in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"} and [5](#fig5){ref-type="fig"}, and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} were obtained using a Lightsheet Z.1 microscope (ZEISS). For fixed, immunostained embryos, samples were mounted into a glass capillary sample holder in 1% low-melting NuSieve GTG agarose (Lonza, Cat. No. 50080) in embryo medium with 0.2 µm dark red fluorescent FluoSpheres (Life Technologies, Cat. No. F8807) diluted 1:200,000 from a 2% solids stock. Embryos were imaged at 0°, 45°, 180° and 225° angles ([@bib47]) using identical imaging conditions. For 3D reconstruction, an interactive bead-based registration algorithm was used to determine the threshold that most accurately selects the beads ([@bib39]). Reconstructed images were converted to 8-bit format using ImageJ, and Imaris software (Bitplane) was used for 3D data visualization and video generation. The videos were cropped using Avidemux 2.6.

To visualize the entire embryo in a single image, reconstructed images were first converted to 16-bit files using ImageJ, and equirectangular 2D map projections were then generated ([@bib47]). The 2D maps were re-aligned into Hammer-Aitoff projections using Hugin panorama photo stitcher software (<http://hugin.sourceforge.net>) to orient the peak of pSmad1/5/9 intensity to the ventral pole (left in [Figure 1](#fig1){ref-type="fig"} panels) and the trough of pSmad1/5/9 intensity to the dorsal pole (right in [Figure 1](#fig1){ref-type="fig"} panels). For gradient quantifications in [Figure 1A+B](#fig1){ref-type="fig"} and [Figure 2F--H](#fig2){ref-type="fig"}, the embryo proper was masked using manual polygon selections in Fiji ([@bib46]) in order to exclude signal from the yolk syncytial layer and yolk. The 'Plot Profile' function in Fiji was then applied to the entire masked image to determine ventral-to-dorsal gradients. The background signal of immunostained embryos was determined by finding the lowest value in the profiles of sphere stage embryos ([Figure 1A+B](#fig1){ref-type="fig"}) and the lowest value in the profiles of *chordin^−/−^* embryos ([Figure 2F+G](#fig2){ref-type="fig"}), respectively. These background values were subtracted from the data sets, and the profiles were normalized to the highest value in each data series. The mean and standard error of the normalized data sets was then calculated piece-wise for every point along the ventral-to-dorsal profile.

For transplantation experiments in [Figures 3](#fig3){ref-type="fig"} and [5](#fig5){ref-type="fig"}, imaging began 5 to 20 min post-transplantation and continued for approximately 1 hr (see *Transplantation* section for further details). The following imaging conditions were used:

-   W Plan-Apochromat 20 x objective, 0.5 x zoom

-   dual side light sheets

-   488 nm laser (100 mW) at 6% power (for sfGFP-containing constructs)

-   561 nm laser (20 mW) at 5% power (for double transplantations only; to detect Alexa 546 signal)

-   separate exposure to 488/561 nm lasers (in double transplantation experiments only) to avoid cross-talk

-   exposure time: 250 ms

-   average light sheet thickness: 6.4 µm

-   3 µm intervals between z-slices; 60 slices per embryo (≈180 µm total)

-   5 min intervals between imaging

Gradients were quantified using maximum intensity projections of 15 z-slices similar to the approach in ([@bib34]). A rectangular region of interest abutting the clone with a fixed height of 86.34 μm (corresponding to 189 pixels) and varying widths depending on embryo length was drawn in Fiji ([@bib46]), and the average intensity in 0.457 μm strips was calculated from the maximum intensity projections. Background intensity resulting from autofluorescence was measured similarly in uninjected embryos (for single transplantation experiments, n = 4) or in uninjected embryos transplanted with a clone of cells containing Alexa 546-coupled dextran (for double transplantation experiments, n = 2). A single value for background subtraction was determined by calculating the average of the intensity profile values. After subtracting the background value from the experimental intensity profiles, the data was normalized to the value closest to the clonal source boundary. This approach allows for the comparison of the relative gradient range, which is independent of constant production rates. We assume constant production rates over the relatively short time scales of observation (≈80 min).

Embryos with low signal-to-noise ratios were excluded from analysis.

Fluorescence decrease after photoconversion (FDAP) experiments {#s4-11}
--------------------------------------------------------------

FDAP experiments were carried out as described in ([@bib34]; [@bib42]). Embryos were injected at the one-cell stage with either 60 pg *BMP2b-Dendra2* mRNA + 0.5 ng Alexa 488-dextran (3 kDa, Molecular Probes) or 150 pg *Chordin-Dendra2* mRNA + 0.5 ng Alexa 488-dextran. To assess background fluorescence, embryos were injected with 0.5 ng Alexa 488-dextran only. Embryos were mounted in 1% low melting point agarose in glass-bottom Petri dishes (MatTek Corporation) covered with embryo medium to hydrate the agarose during imaging.

FDAP experiments were performed using an LSM 780 (ZEISS) confocal microscope. Pre-conversion and post-conversion images were acquired using an LD C-Apochromat 40x/1.1 NA water immersion objective. A single pre-photoconversion image was first acquired for each sample followed by photoconversion and multiposition time-lapse imaging with 10 min intervals for approximately 300 min. For photoconversion, embryos were illuminated with a Sola SE II LED lamp at 100% power for 30 s through a C-Apochromat 10x/0.45 NA objective and an AHF F36-500 UV filter cube. For both pre- and post-conversion images, Alexa 488 was excited using a 488 nm Argon laser, and a DPSS 561 nm laser was used to excite photoconverted Dendra2. The emission signal between 494--576 nm (Alexa 488) and 578--696 nm (photoconverted Dendra2) was collected using a 32 channel GaAsP QUASAR detector array. Embryos that produced only low levels of photoconverted Dendra2 signal or whose position shifted significantly over time as well as embryos with non-uniform signal distribution or embryos that died were excluded from analysis. Sample numbers: n = 22 for BMP2b-Dendra2 (with n = 17 background embryos); n = 6 for Chordin-Dendra2 (with n = 1 background embryo).

All experiments were analyzed using PyFDAP ([@bib8]; [@bib42]), version 1.1.2. PyFDAP extracts the extracellular and intracellular photoconverted Dendra2 signal by masking the Alexa 488 signal, and fits the resulting average intensities with a linear decay model. The ordinary differential equation describing linear protein decay is given by$$\frac{dc}{dt} = - k_{1}c$$

where *c* is the concentration of the protein and *k~1~* is its clearance rate constant. We assume that Dendra2 signal is directly proportional to the protein concentration. The analytical solution of this equation is given by$$c\left( t \right) = c_{0}e^{- k_{1}t} + y_{0}$$

where *c~0~* + *y~0~* is the protein\'s concentration at *t = 0,* and *y~0~* is the protein\'s concentration at *t =* ∞. The half-life τ of the protein can then be calculated as$$\tau = {ln}\left( 2 \right)/k$$

PyFDAP estimates a lower bound for *y~0~* by computing the maximum relative effect of photobleaching *F~i,r~*. For each background data set, the strongest influence of photobleaching was computed by taking the minimum over all differences of background intensity *B~j,r~* and background noise *N~i~*, and the difference between pre-conversion background intensity *B*~pre,*i,r*~ and noise level. Here, *r* denotes the region under consideration, i.e. extracellular, intracellular, or the entire imaging slice; *i* indicates the *i*th data set, and *j* counts the background data sets. The average over all *b* background data sets was then taken to arrive at the mean effect of photobleaching. The factor$$F_{i,r} = \frac{1}{b}\sum\limits_{j = 1}^{b}\underset{t}{min}\left( \frac{B_{j,r}\left( t \right) - N_{i}}{B_{\text{pre}_{j,r}} - N_{i}} \right)$$

was used to scale the pre-conversion intensity of the FDAP data set according to$$y_{0_{i,r}} \geq F_{i,r}\left( {I_{\text{pre}_{i,r}} - N_{i}} \right) + N_{i}$$

This lower bound was then used to constrain a Nelder-Mead simplex algorithm when minimizing$$SSD = {\sum\limits_{n}\left( \overline{I}\left( t_{n} \right) - c\left( t_{n} \right) \right)^{2}}$$

Fluorescence recovery after photobleaching (FRAP) experiments {#s4-12}
-------------------------------------------------------------

FRAP experiments and data analysis were carried out as previously described ([@bib34]; [@bib35]) using an LSM 780 NLO confocal microscope (ZEISS) and an LD LCI Plan-Apochromat 25x water immersion objective. Embryos were injected at the one-cell stage with 30 pg of mRNA encoding BMP2b-sfGFP, 60 pg of mRNA encoding BMP2b-Dendra2, 60 pg of mRNA encoding Chordin-sfGFP, 120 pg of mRNA encoding Chordin-Dendra2, or 30 pg of mRNA encoding Sizzled-sfGFP. To analyze the effect of Chordin on BMP2b diffusion, embryos were injected at the one-cell stage with 30 pg of mRNA encoding BMP2b-sfGFP plus 60 or 200 pg of mRNA encoding Chordin, or 60 pg of mRNA encoding BMP2b-Dendra2 plus 200 pg of mRNA encoding Chordin. Embryos were mounted in 1% low-melting point agarose in glass-bottom Petri dishes (MatTek Corporation) covered with embryo medium to hydrate the agarose during imaging. Embryos with low or non-uniform fluorescence and embryos that died or whose position shifted significantly over time were excluded from analysis.

For FRAP data analysis, the fits of a model with uniform production, diffusion, and clearance were constrained with the clearance rate constants of BMP2b-Dendra2 and Chordin-Dendra2 fusions measured by FDAP in the present study (BMP2b-Dendra2: *k~1~* = 8.9 × 10^−5^/s; Chordin-Dendra2: *k~1~* = 9.6 × 10^−5^/s). Sizzled-sfGFP fits were constrained with the clearance constant measured for BMP2b-Dendra2 assuming similar protein stability. As shown previously, the estimation of diffusion coefficients does not sensitively depend on the values of clearance rate constants if the time scales of observation (here: 50 min) and protein stability (here: approximately 120 min) are similar ([@bib34]).

Fluorescence correlation spectroscopy (FCS) experiments {#s4-13}
-------------------------------------------------------

The FCS experiments were done using an LD C-Apochromat 40x/1.1 NA water immersion objective on an LSM 780 NLO confocal microscope (ZEISS). Embryos were injected at the one-cell stage with 30 pg of mRNA encoding BMP2b-sfGFP or 60 pg of mRNA encoding Chordin-sfGFP. Embryos were mounted in 1% low-melting point agarose in glass-bottom Petri dishes (MatTek Corporation) and covered with embryo medium to hydrate the agarose during imaging. The fluorophores (sfGFP, Alexa 488) were excited using an Argon 488 nm laser, and the emission light between 494 and 542 nm was collected using a 32-channel GaAsP QUASAR detector array. Before each FCS experiment, the pinhole was aligned and set to 1 Airy unit, and the instrument was calibrated using a solution of 40 nM Alexa 488 dye (Thermo Fisher) in water. For each FCS sample, fluorescence fluctuations were measured for 10 s with 10 repeats, and any irregularities in the 100 s count trace resulting from cellular movements were excluded from analysis.

Auto-correlation curves for Alexa 488 were freely fitted to determine the structural parameter as well as the diffusion time, the triplet state fraction, and the triplet state relaxation time of Alexa 488 for every experiment. The auto-correlation curves for BMP2b-sfGFP and Chordin-sfGFP were fitted with a fixed structural parameter, fixed triplet state fraction, and fixed triplet relaxation time determined from the Alexa 488 calibration measurements. The curves were fitted using ZEISS ZEN Pro software with a one-component 'free diffusion with triplet state correction' model. The first 10^−6^ seconds lag time for the correlation curve was excluded in the fitting ([@bib53]; [@bib35]). The diffusion coefficient was then calculated by comparing the diffusion time of BMP2b-sfGFP and Chordin-sfGFP with Alexa 488 (reference diffusion coefficient: 435 μm^2^/s \[[@bib36]\]).

Since the values of the triplet state fraction and the triplet state relaxation time of sfGFP are unknown and not necessarily identical to those of Alexa 488, we also freely fitted the autocorrelation curves for BMP2b-sfGFP and Chordin-sfGFP with the experimentally measured structural parameter as the only constraint, and determined free diffusion coefficients of *D* = 35 ± 2 μm^2^/s for BMP2b-sfGFP (n = 17 measurements from 4 embryos) and *D* = 50 ± 3 μm^2^/s for Chordin-sfGFP (n = 19 measurements from 5 embryos), within a deviation of approximately 20--30% compared to the diffusion coefficients determined by constraining the fits with a fixed structural parameter, fixed triplet state fraction, and fixed triplet relaxation time (*D* = 46 ± 1 μm^2^/s for BMP2b-sfGFP, and *D* = 59 ± 2 μm^2^/s for Chordin-sfGFP; values reported in [Figure 4](#fig4){ref-type="fig"}). The similar diffusion coefficients determined by differently constrained fits indicate that the diffusion time measured in our experiments does not sensitively depend on the values of the triplet state fraction and triplet state relaxation time.

Mathematical modeling of BMP2b-sfGFP and Chordin-sfGFP gradient formation {#s4-14}
-------------------------------------------------------------------------

The geometry of the zebrafish blastoderm was approximated by the complement of two spheres with a columnar subdomain placed off-center to represent the signal source region with the same parameters as described in [@bib34]. Gradient formation was simulated with the source-diffusion-sink model$$\frac{\partial c}{\partial t} = D\nabla^{2}c - k_{1}c + \delta_{s}k_{2}$$

with$$\delta_{\text{s}} = \left\{ \begin{matrix}
1 & {in\ the\ source} \\
0 & {otherwise} \\
\end{matrix} \right.$$

For [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}, the experimental data were fitted with solutions from a 50 × 50 parameter grid spanning all possible combinations of 50 diffusion coefficients (logarithmically spaced from 0.1 µm^2^/s to 50 µm^2^/s) and 50 clearance rate constants (logarithmically spaced from 1 × 10^−5^/s to 5 × 10^−4^).

Simulations of previous models {#s4-15}
------------------------------

The finite element method was used for all numerical simulations. All geometries are one-dimensional representations of embryos. The solution at each time step in the discretized geometries was determined using a sparse LU factorization algorithm (UMFPACK), and the time stepping was computed using a backward Euler step method (Comsol Multiphysics). Simulations in [Figure 1C--E,G](#fig1){ref-type="fig"} (Models 1, 2, 3, and 5) were executed for a total of 10080 s (i.e., for approximately 3 hr from sphere to shield stage during zebrafish embryogenesis \[[@bib25]\]) and read out every 2520 s (i.e., approximately every 42 min at relevant zebrafish stages). The simulation in [Figure 1F](#fig1){ref-type="fig"} (Model 4) was executed for a total of 20 time steps near steady state and read out at every fifth time step.

The following model descriptions comprise the complete wild type systems. For simulations of *chordin* mutants, the Chordin flux was set to 0 (Models 1, 2, 3, and 5), or the Chordin-dependent terms were removed from the equations and the initial concentration of Chordin was set to 0 (Model 4). To focus on the role of Chordin in regulating BMP signaling and distribution, we did not include other negative regulators of BMP such as Noggin and Follistatin ([@bib50]). For the interpretation of the simulations, we assume that the distribution of free BMPs is correlated with BMP signaling and the distribution of pSmad1/5/9.

To facilitate comparison of the models, the distribution profiles of free BMP are shown as a function of relative embryo length, and the solutions were normalized to the ventral-most free BMP concentration at shield stage (i.e., at *t* = 7560 s for Models 1, 2, 3, and 5, and at *t* = 15 for Model 4) in wild type simulations.

Model 1: Graded source-sink (mobile BMP) {#s4-16}
----------------------------------------

In the graded source-sink model, the BMP source *ρ~BMP~*(x) was modeled after the known distribution of *bmp2b* mRNA between sphere stage and 30% epiboly ([@bib41]). The model does not include autoregulation of BMP production since positive feedback only appears to be important for later stages of development ([@bib41]; [@bib54]). Chordin binds BMP irreversibly and acts as a sink. The model was simulated using the following equations:$$\begin{matrix}
 & {\frac{\partial\lbrack\text{BMP}\rbrack}{\partial t} = D_{\text{BMP}}\nabla^{2}\lbrack\text{BMP]} - \kappa\lbrack\text{Chd}\rbrack\lbrack\text{BMP}\rbrack - \lambda_{\text{BMP}}\lbrack\text{BMP}\rbrack + \rho_{\text{BMP}}(x)} \\
 & \\
 & {\frac{\partial\lbrack\text{Chd}\rbrack}{\partial t} = D_{\text{Chd}}\nabla^{2}\lbrack\text{Chd}\rbrack - \kappa\lbrack\text{Chd}\rbrack\lbrack\text{BMP}\rbrack - \lambda_{\text{Chd}}\lbrack\text{Chd}\rbrack} \\
 & \\
 & {\frac{\partial\lbrack\text{ChdBMP}\rbrack}{\partial t} = D_{\text{ChdBMP}}\nabla^{2}\lbrack\text{ChdBMP}\rbrack + \kappa\lbrack\text{Chd}\rbrack\lbrack\text{BMP}\rbrack - \lambda_{\text{Chd}}\lbrack\text{ChdBMP}\rbrack} \\
\end{matrix}$$

### Embryo geometry and boundary conditions {#s4-16-1}

Embryo length: 300 × 10^−6^ m (300 µm, the typical length of the zebrafish blastoderm)

Constant Chordin flux from the dorsal boundary: 5 × 10^−14^ mol/(m^2^∙s)

No-flux boundary condition for all other species on both ventral and dorsal boundaries

### Parameter values {#s4-16-2}

*D~BMP~* = 2 µm^2^/s (measured in the present study)

*D~Chd~* = 7 µm^2^/s (measured in the present study)

*D~ChdBMP~* = 7 µm^2^/s

λ~BMP~ = 8.9 × 10^−5^/s (measured in the present study)

λ~Chd~ = 9.6 × 10^−5^/s (measured in the present study)

*κ* = 400 × 10^3^ m^3^/(mol∙s)

*ρ~BMP~*(x) = 0.57 × 10^−9^ × *e*^-5000x ^mol/m^3^ (accounting for the inhomogeneous ventrally peaking distribution of *bmp2b* mRNA in zebrafish embryos)

### Initial conditions {#s4-16-3}

BMP initial concentration: 2.85 × 10^−8^ mol/m^3^ everywhere (one-twentieth of the concentration used for *Xenopus* frogs in \[[@bib22]\])

Chordin initial concentration: 0 mol/m^3^ everywhere

Chordin-BMP complex initial concentration: 0 mol/m^3^ everywhere

Model 2: Graded source-sink (immobile BMP) {#s4-17}
------------------------------------------

As for Model 1, the graded source-sink model (immobile BMP) was modeled without autoregulation of BMP production since positive feedback only appears to be important for later stages of development ([@bib41]; [@bib54]). Here *κ*, which reflects the binding between Chordin and BMP, is smaller than in Model 1 to obtain a realistic-free BMP distribution; using the same value for *κ* as in Model 1 creates an unrealistically steep free BMP gradient. The model was simulated using the following equations:$$\begin{matrix}
 & {\frac{\partial\left\lbrack \text{BMP} \right\rbrack}{\partial t} = - \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack - \lambda_{\text{BMP}}\left\lbrack \text{BMP} \right\rbrack + \rho_{\text{BMP}}(x)} \\
 & \\
 & {\frac{\partial\left\lbrack \text{Chd} \right\rbrack}{\partial t} = D_{\text{Chd}}\nabla^{2}\left\lbrack \text{Chd} \right\rbrack - \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack - \lambda_{\text{Chd}}\left\lbrack \text{Chd} \right\rbrack} \\
 & \\
 & {\frac{\partial\left\lbrack \text{ChdBMP} \right\rbrack}{\partial t} = D_{\text{ChdBMP}}\nabla^{2}\left\lbrack \text{ChdBMP} \right\rbrack + \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack - \lambda_{\text{Chd}}\left\lbrack \text{ChdBMP} \right\rbrack} \\
\end{matrix}$$

### Embryo geometry and boundary conditions {#s4-17-1}

Embryo length: 300 × 10^−6^ m (300 µm, the typical length of a zebrafish blastoderm)

Constant Chordin flux from the dorsal boundary: 5 × 10^−14^ mol/(m^2^∙s)

No-flux boundary condition for all other species on both ventral and dorsal boundaries

### Parameter values {#s4-17-2}

*D~Chd~* = 7 µm^2^/s (measured in the present study)

*D~ChdBMP~* = 7 µm^2^/s

λ~BMP~ = 8.9 × 10^−5^/s (measured in the present study)

λ~Chd~ = 9.6 × 10^−5^/s (measured in the present study)

*κ* = 4 × 10^3^ m^3^/(mol∙s)

*ρ~BMP~*(x) = 0.57 × 10^−9^ × *e*^-5000x ^mol/m^3^ (accounting for the inhomogenous ventrally peaking distribution of *bmp2b* mRNA in zebrafish embryos)

### Initial conditions {#s4-17-3}

BMP initial concentration: 2.85 × 10^−8^ mol/m^3^ everywhere (one-twentieth of the concentration used for *Xenopus* frogs in \[[@bib22]\]).

Chordin initial concentration: 0 mol/m^3^ everywhere

Chordin-BMP complex initial concentration: 0 mol/m^3^ everywhere

Model 3: Long-range accumulation and feedback {#s4-18}
---------------------------------------------

The model was developed for frog embryogenesis. For the simulations in the present study the equations, geometry, initial conditions, and parameters used were exactly as described in ([@bib22]):$$\begin{matrix}
 & {\frac{\partial\lbrack\text{BMP}\rbrack}{\partial t} = D\nabla^{2}\lbrack\text{BMP}\rbrack + \frac{v_{\text{BMP}}(\lbrack\text{ADMP}\rbrack + \lbrack\text{BMP}\rbrack)^{10}}{k_{\text{BMP}}^{10} + (\lbrack\text{ADMP}\rbrack + \lbrack\text{BMP}\rbrack)^{10}} - \lambda_{\text{BMP}}\lbrack\text{BMP]}} \\
 & \\
 & \\
 & {+ {\frac{\lambda_{\text{Chd}}\lbrack\text{ChdBMP]}}{1 + {\frac{\lbrack\text{Szl}\rbrack}{ki} + \frac{\lbrack\text{Chd}\rbrack + \lbrack\text{ChdBMP}\rbrack + \lbrack\text{ChdADMP}\rbrack}{km}}} - k\lbrack\text{Chd}\rbrack\lbrack\text{BMP}\rbrack}} \\
 & \\
 & \\
 & {\frac{\partial\lbrack\text{Chd}\rbrack}{\partial t} = D\nabla^{2}\lbrack\text{Chd}\rbrack + \frac{v_{\text{Chd}}k_{\text{Chd}}^{10}}{k_{\text{Chd}}^{10} + (\lbrack\text{ADMP}\rbrack + \lbrack\text{BMP}\rbrack)^{10}} - \frac{\lambda_{\text{Chd}}\lbrack\text{Chd]}}{1 + {\frac{\lbrack\text{Szl}\rbrack}{ki} + \frac{\lbrack\text{Chd}\rbrack + \lbrack\text{ChdBMP}\rbrack + \lbrack\text{ChdADMP}\rbrack}{km}}}} \\
 & {- k\lbrack\text{Chd}\rbrack\lbrack\text{BMP\ ]} - k\lbrack\text{Chd}\rbrack\lbrack\text{ADMP]}} \\
 & \\
 & {\frac{\partial\lbrack\text{ADMP}\rbrack}{\partial t} = D\nabla^{2}\lbrack\text{ADMP}\rbrack + \frac{v_{\text{ADMP}}k_{\text{ADMP}}^{10}}{k_{\text{ADMP}}^{10} + (\lbrack\text{ADMP}\rbrack + \lbrack\text{BMP}\rbrack)^{10}} - \lambda_{\text{BMP}}\lbrack\text{ADMP}\rbrack} \\
 & \\
 & \\
 & {+ {\frac{\lambda_{\text{Chd}}\lbrack\text{ChdADMP]}}{1 + {\frac{\lbrack\text{Szl}\rbrack}{ki} + \frac{\lbrack\text{Chd}\rbrack + \lbrack\text{ChdBMP}\rbrack + \lbrack\text{ChdADMP}\rbrack}{km}}} - k\lbrack\text{Chd}\rbrack\lbrack\text{ADMP]}}} \\
 & \\
 & \\
 & {\frac{\partial\lbrack\text{Szl}\rbrack}{\partial t} = D\nabla^{2}\lbrack\text{Szl}\rbrack + \frac{v_{\text{Szl}}(\lbrack\text{ADMP}\rbrack + \lbrack\text{BMP}\rbrack)^{20}}{k_{\text{Szl}}^{20} + (\lbrack\text{ADMP}\rbrack + \lbrack\text{BMP}\rbrack)^{20}} - \lambda_{\text{Szl}}\lbrack\text{Szl}\rbrack} \\
 & \\
 & \\
 & {\frac{\partial\lbrack\text{ChdBMP}\rbrack}{\partial t} = D\nabla^{2}\lbrack\text{ChdBMP}\rbrack - \frac{\lambda_{\text{Chd}}\lbrack\text{ChdBMP}\rbrack}{1 + {\frac{\lbrack\text{Szl}\rbrack}{ki} + \frac{\lbrack\text{Chd}\rbrack + \lbrack\text{ChdBMP}\rbrack + \lbrack\text{ChdADMP}\rbrack}{km}}} + k\lbrack\text{Chd}\rbrack\lbrack\text{BMP}\rbrack} \\
 & \\
 & \\
 & {\frac{\partial\lbrack\text{ChdADMP}\rbrack}{\partial t} = D\nabla^{2}\lbrack\text{ChdADMP}\rbrack - \frac{\lambda_{\text{Chd}}\lbrack\text{ChdADMP}\rbrack}{1 + {\frac{\lbrack\text{Szl}\rbrack}{ki} + \frac{\lbrack\text{Chd}\rbrack + \lbrack\text{ChdBMP}\rbrack + \lbrack\text{ChdADMP}\rbrack}{km}}} + k\lbrack\text{Chd}\rbrack\lbrack\text{ADMP}\rbrack} \\
\end{matrix}$$

### Embryo geometry and boundary conditions {#s4-18-1}

Embryo length: 1000 × 10^−6^ m (1000 µm, the typical length of a frog embryo)

Constant Chordin flux from the dorsal boundary: 4.8 × 10^−12^ mol/(m^2^∙s)

No-flux boundary condition for all other species on both ventral and dorsal boundaries

### Parameter values  {#s4-18-2}

*km* = 25 × 10^−6^ mol/m^3^

*ki* = 25 × 10^−6^ mol/m^3^

*v~Chd~* = 5 × 10^−10^ mol/(m^3^∙s) 

*k~Chd~* = 7 × 10^−8^ mol/m^3^

*v~BMP~* = 1.4 × 10^−10^ mol/(m^3^∙s) 

*k~BMP~* = 3.5 × 10^−7^ mol/m^3^

*v~Szl~* = 100 × 10^−6^ mol/(m^3^∙s) 

*k~Szl~* = 1 × 10^−6^ mol/m^3^

*v~ADMP~* = 3.2 × 10^−9^ mol/(m^3^∙s) 

*k~ADMP~* = 3 × 10^−8^ mol/m^3^

*λ~Chd~* = 1 × 10^−3^/s

*λ~BMP~* = 2 × 10^−4^/s

*λ~Szl~* = 3.8 × 10^−5^/s

*D* = 15 µm^2^/s

*k* = 280 m^3^/(mol∙s)

### Initial conditions {#s4-18-3}

BMP initial concentration: 0.57 × 10^−6^ × *e*^-1000x^ mol/m^3^ throughout the embryo (the amplitude of this distribution is the same as in \[[@bib22]\], but the initial BMP profile was modeled as a gradient instead of uniform)

Chordin initial concentration: 0 mol/m^3^ everywhere

ADMP initial concentration: 0 mol/m^3^ everywhere

Sizzled initial concentration: 0 mol/m^3^ everywhere

Chordin-BMP complex initial concentration: 0 mol/m^3^ everywhere

Chordin-AMP complex initial concentration: 0 mol/m^3^ everywhere

For the simulations in [Figure 4---figure supplement 1E--J](#fig4s1){ref-type="fig"}, all parameters were identical to the parameter values listed above except for *D*(BMP) = 3 µm^2^/s, *D*(Chd) = 6 µm^2^/s, *D*(ChdADMP) = 10 µm^2^/s, and *D*(ChdBMP) = 10 µm^2^/s. *D*(Sizzled) was set to 150 µm^2^/s in [Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}, and to 10 µm^2^/s in [Figure 4---figure supplement 1F--J](#fig4s1){ref-type="fig"}. *D*(ADMP) was varied from 0.1 µm^2^/s to 150 µm^2^/s as indicated in [Figure 4---figure supplement 1E--J](#fig4s1){ref-type="fig"}.

Model 4: Self-regulating reaction-diffusion system {#s4-19}
--------------------------------------------------

The non-dimensional model, geometry, initial conditions, and parameters used for the simulations were similar to the ones described in \[[@bib16]\]:$$\begin{matrix}
 & {\frac{\partial\lbrack\text{BMP}\rbrack}{\partial t} = D_{\text{BMP}}\nabla^{2}\lbrack\text{BMP}\rbrack + \frac{\lbrack\text{BMP}\rbrack^{2}}{(1 + \lbrack\text{Chd}\rbrack)\lbrack\text{Szl}\rbrack} - \mu_{\text{BMP}}\lbrack\text{BMP]} + \rho_{\text{BMP}}} \\
 & \\
 & {\frac{\partial\lbrack\text{Chd}\rbrack}{\partial t} = D_{\text{Chd}}\nabla^{2}\lbrack\text{Chd}\rbrack + \frac{\lbrack\text{Chd}\rbrack^{2}}{\text{[ADMP}\rbrack} - \mu_{\text{Chd}}\lbrack\text{Chd}\rbrack + \rho_{\text{Chd}}} \\
 & \\
 & {\frac{\partial\lbrack\text{ADMP}\rbrack}{\partial t} = D_{\text{ADMP}}\nabla^{2}\lbrack\text{ADMP}\rbrack + \lbrack\text{Chd}\rbrack^{2} - \mu_{\text{ADMP}}\lbrack\text{ADMP}\rbrack} \\
 & \\
 & {\frac{\partial\lbrack\text{Szl}\rbrack}{\partial t} = D_{\text{Szl}}\nabla^{2}\lbrack\text{Szl}\rbrack + \lbrack\text{BMP}\rbrack^{2} - \mu_{\text{Szl}}\lbrack\text{Szl}\rbrack} \\
\end{matrix}$$

### Embryo geometry and boundary conditions {#s4-19-1}

Embryo length: 25

No-flux boundary conditions on the ventral and dorsal boundaries

### Parameter values {#s4-19-2}

*D~Chd~* = *D~BMP~* = 6

*µ~Chd~* = *µ~BMP~* = 1.2

*ρ~Chd~* = *ρ~BMP~* = 0.1

*µ~ADMP~* = *µ~Szl~* = 1.5

*D~ADMP~* = *D~Szl~* = 150

### Initial conditions {#s4-19-3}

BMP initial concentration: *ρ~BMP~* = *e*^-0.1x^

Chordin initial concentration of 1 from position 0 to 24 and Chordin initial concentration of 10 from 24 to 25 (i.e., the dorsal organizer) in the simulated embryo

ADMP initial concentration: 1 everywhere

Sizzled initial concentration: 1 everywhere

For the simulations in [Figure 4---figure supplement 1K--P](#fig4s1){ref-type="fig"}, all parameters were identical to the parameter values listed above except for *D*(BMP) = 3 and *D*(Chd) = 6. *D*(Sizzled) was set to 150 in [Figure 4---figure supplement 1K](#fig4s1){ref-type="fig"}, and to 10 in [Figure 4---figure supplement 1L--P](#fig4s1){ref-type="fig"}. *D*(ADMP) was varied from 0.1 to 150 as indicated in [Figure 4---figure supplement 1K--P](#fig4s1){ref-type="fig"}.

Model 5: Shuttling {#s4-20}
------------------

For Model 5, a minimal transport model that excludes the effects of downstream patterning circuits was used to illustrate the biophysical aspects of shuttling ([@bib3]):$$\begin{matrix}
 & {\frac{\partial\left\lbrack \text{BMP} \right\rbrack}{\partial t} = D_{\text{BMP}}\nabla^{2}\left\lbrack \text{BMP} \right\rbrack - \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack + \lambda\left\lbrack \text{Xlr} \right\rbrack\left\lbrack \text{ChdBMP} \right\rbrack - \lambda_{\text{BMP}}\left\lbrack \text{BMP} \right\rbrack + \rho_{\text{BMP}}(x)} \\
 & \\
 & {\frac{\partial\left\lbrack \text{Chd} \right\rbrack}{\partial t} = D_{\text{Chd}}\nabla^{2}\left\lbrack \text{Chd} \right\rbrack - \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack - \lambda_{\text{Chd}}\left\lbrack \text{Chd} \right\rbrack} \\
 & \\
 & {\frac{\partial\left\lbrack \text{ChdBMP} \right\rbrack}{\partial t} = D_{\text{ChdBMP}}\nabla^{2}\left\lbrack \text{ChdBMP} \right\rbrack + \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack - \lambda\left\lbrack \text{Xlr} \right\rbrack\left\lbrack \text{ChdBMP} \right\rbrack - \lambda_{\text{Chd}}\left\lbrack \text{ChdBMP} \right\rbrack} \\
\end{matrix}$$

### Embryo geometry and boundary conditions {#s4-20-1}

Embryo length: 300 × 10^−6^ m (300 µm)

Constant Chordin flux from the dorsal boundary: 3 × 10^−14^ mol/(m^2^∙s)

No-flux boundary condition for all other species on both ventral and dorsal boundaries

### Parameter values {#s4-20-2}

*D~BMP~* = 0.1 µm^2^/s

*D~Chd~* = 10 µm^2^/s

*D~ChdBMP~* = 10 µm^2^/s

λ~BMP~ = 8.9 × 10^−5^/s (measured in the present study)

λ~Chd~ = 9.6 × 10^−5^/s (measured in the present study)

*κ* = 100 × 10^3^ m^3^/(mol∙s)

*λ* = *κ*

\[Xlr\] = 2 × 10^−8^ mol/m^3^

*ρ~BMP~*(x) = 0.57 × 10^−10^ × *e*^-5000x ^mol/m^3^ (accounting for the inhomogeneous ventrally peaking distribution of *bmp2b* mRNA in zebrafish embryos)

### Initial conditions {#s4-20-3}

BMP initial concentration: 0.57 × 10^−7^ × *e*^-5000x^ mol/m^3^ throughout the embryo

Chordin initial concentration: 0 mol/m^3^ everywhere

Chordin-BMP complex initial concentration: 0 mol/m^3^ everywhere

Shuttling simulations of adjacent BMP and Chordin clones shown in [Figure 5](#fig5){ref-type="fig"} {#s4-21}
---------------------------------------------------------------------------------------------------

The one-dimensional simulations in [Figure 5](#fig5){ref-type="fig"} were executed similarly to the ones described above and solved at 15 and 75 min for comparison to the zebrafish embryo double transplantation experiments. The solutions in [Figure 5A](#fig5){ref-type="fig"} and [Figure 5E](#fig5){ref-type="fig"} were normalized to the highest free BMP concentration in the simulation without the Chordin source, and the solutions in [Figure 5B](#fig5){ref-type="fig"} and [Figure 5F](#fig5){ref-type="fig"} were normalized to the free BMP concentration at the BMP source boundary (at 100 μm) for each condition to facilitate comparison between the gradient ranges.

The double transplantation experiments were modeled using the following equations:$$\begin{matrix}
 & {\frac{\partial\left\lbrack \text{BMP} \right\rbrack}{\partial t} = D_{\text{BMP}}\nabla^{2}\left\lbrack \text{BMP} \right\rbrack - \lambda_{\text{BMP}}\left\lbrack \text{BMP} \right\rbrack - \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack + \lambda\left\lbrack \text{Xlr} \right\rbrack\left\lbrack \text{ChdBMP} \right\rbrack + \delta_{\text{BMP}}\eta_{\text{BMP}}} \\
 & \\
 & {\frac{\partial\left\lbrack \text{Chd} \right\rbrack}{\partial t} = D_{\text{Chd}}\nabla^{2}\left\lbrack \text{Chd} \right\rbrack - \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack + \delta_{\text{Chd}}\eta_{\text{Chd}}} \\
 & \\
 & {\frac{\partial\left\lbrack \text{ChdBMP} \right\rbrack}{\partial t} = D_{\text{ChdBMP}}\nabla^{2}\left\lbrack \text{ChdBMP} \right\rbrack + \kappa\left\lbrack \text{Chd} \right\rbrack\left\lbrack \text{BMP} \right\rbrack - \lambda\left\lbrack \text{Xlr} \right\rbrack\left\lbrack \text{ChdBMP} \right\rbrack} \\
\end{matrix}$$

with$$\delta_{\text{BMP}} = \left\{ \begin{matrix}
 & {\!\!\!\!\!\! 1\ {in\ the\ BMP\ source}} \\
 & {\!\!\!\!\!\! 0\ {otherwise}} \\
\end{matrix} \right.$$

and$$\delta_{\text{Chd}} = \left\{ \begin{matrix}
 & {\!\!\!\!\!\! 1\ {in\ the\ Chordin\ source}} \\
 & {\!\!\!\!\!\! 0\ {otherwise}} \\
\end{matrix} \right.$$

### Embryo geometry and boundary conditions {#s4-21-1}

Embryo length: 300 × 10^−6^ m (300 µm)

BMP source: between 50 and 100 µm from the left boundary

Chordin source: between 200 and 250 µm from the left boundary

No-flux boundary conditions on the left and right boundaries

### Parameter values for simulations of shuttling predictions ([Figure 5A+B](#fig5){ref-type="fig"}) {#s4-21-2}

*D~BMP~* = 2 µm^2^/s (measured in the present study)

*λ~BMP~ = * 0.0001/s (similar to measurements in the present study)

*η~BMP~ = * 5 × 10^−5^ mol/(m^3^∙s)

*η~Chd~ = * 5 × 10^−5^ mol/(m^3^∙s)

*D~Chd~* = 100 µm^2^/s

*D~ChdBMP~* = *D~Chd~*

*κ* = 10 × 10^3^ m^3^/(mol∙s)

*λ* = *κ*

\[Xlr\] = 2 × 10^−7^ mol/m^3^

### Parameter values for simulations with experimentally measured diffusivities ([Figure 5E+F](#fig5){ref-type="fig"}) {#s4-21-3}

*D~BMP~* = 2 µm^2^/s (measured in the present study)

*λ~BMP~ = * 0.0001/s (similar to measurements in the present study)

*η~BMP~ = * 5 × 10^−5^ mol/(m^3^∙s)

*η~Chd~ = * 5 × 10^−5^ mol/(m^3^∙s)

*D~Chd~* = 6 µm^2^/s (measured in the present study)

*D~ChdBMP~* = 2.2 µm^2^/s (measured in the present study)

*κ* = 10 × 10^3^ m^3^/(mol s)

*λ* = *κ*

\[Xlr\] = 2 × 10^−7^ mol/m^3^

### Initial conditions {#s4-21-4}

BMP initial concentration: 0 mol/m^3^ everywhere

Chordin initial concentration: 0 mol/m^3^ everywhere

Chordin-BMP complex initial concentration: 0 mol/m^3^ everywhere
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Dynamics of BMP signaling and distribution during zebrafish dorsal-ventral patterning\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Deborah Yelon as the Reviewing Editor and by Didier Stainier as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, Pomreinke et al. examine an intensely debated topic: the mechanism by which BMP and Chordin pattern the dorsal-ventral axis in the early zebrafish embryo. Recent years have seen a proliferation of papers using elaborate models that assume very specific differences between the stabilities and mobilities of ligands and inhibitors, but these parameters are rarely measured directly. Here, the authors perform careful biophysical measurements in order to provide new quantitative information regarding the relevant rates of diffusion and degradation. Their data show that BMP2b and Chordin have similar stabilities and that Chordin is slightly more diffusive. They also show that, in the absence of Chordin, BMP signaling activity is lower on the ventral side but higher dorsally. These are useful observations that represent an advance in determining how the BMP gradient forms. Moreover, this work provides insight into some of the previously proposed models to explain how dorsoventral patterning takes place. Specifically, the authors\' data undermine model \#4 (shuttling) and provide partial evidence to support model \#2 (self-organizing reaction-diffusion system). However, the experimental and theoretical analysis performed here do not yet completely support the authors\' claims. Further evidence is needed to strengthen their conclusions, as detailed in the requested Essential Revisions below.

Essential revisions:

1\) The authors present four models for the mechanism by which BMP and Chordin pattern the dorsal-ventral axis, but it is not convincing that these fully represent the current understanding in the field. For example, there are also source-sink models that need to be considered.

2\) Of the three major conclusions (Discussion, third paragraph), conclusion 1 (Chordin generates signaling peak; reaction-diffusion explains DV patterning) is not convincing, conclusion 2 (BMP does diffuse) is unsurprising, but conclusion 3 (Chordin is more diffusive than BMP) is well supported. In addition, an important fourth conclusion (Chordin does not affect BMP diffusion) should be added.

3\) Absolute signaling levels are difficult to measure and compare. How sure are the authors that in the absence of chordin BMP signaling activity is lower on the ventral side?

4\) Previous work has shown that chordin mRNA injections at the 1-cell stage rescue zebrafish chordino mutants (Schulte-Merker et al., 1997). Moreover, this brief exposure to uniform Chordin in early embryos is sufficient to generate a normal axial skeleton and fins in rescued mutants, and to grow to adulthood (Fisher and Halpern, 1999). These in vivo observations (of rescue with uniform chordin at early stages) contrast with three theoretical models (Pure inhibition, Long-range accumulation and feedback, Shuttling), which presume a localized Chordin source and point towards the self-organizing system in model \#2. It would therefore be valuable for the authors to computationally model how the BMP gradient forms in rescued chordino mutants using parameters that generate uniform Chordin in early embryos. e.g., instead of the assumed/theoretical values in subsections "Simulations of previous models" and "Shuttling simulations of adjacent BMP and Chordin clones shown in Figure 5", they could test constant and uniform Chordin from dorsal\>ventral. Varying the exposure time to uniform Chordin in the simulations would also be informative, i.e., uniform Chordin at early stages vs. uniform early and then localised at the onset of gastrulation, etc.

5\) To complement their analysis of bmp/swirl mutants (rescued with bmp2b RNA injections), the authors could experimentally determine by live imaging how the BMP2b-sfGFP gradient forms in chordino mutant embryos upon rescue with chordin RNA injections at the 1-cell stage. Alternatively, measurement of P-Smad levels (as in Figure 1B and Figure 2F) could be sufficient to demonstrate how BMP activity is affected by uniform Chordin.

6\) Figure 3: Is BMP2b-sfGFP / Chordin-sfGFP protein expression initially uniform in the injected embryos at late blastula/early gastrula stages (before transplantations to host embryos)? The authors should show this.

7\) Results, sixth paragraph: In addition to differences in stability or diffusivity, the production rates of the two proteins could also be different. In Figure 4A+B, it seems that Chordin is detected slightly later than BMP2b. The authors should discuss this.

8\) Figure 3---figure supplement Figure 1C: There is a substantial low molecular weight band in the cellular fraction corresponding to cleaved BMP2 (green asterisk in the extracellular enriched fraction) -- why is this detected in the cellular fraction? Is there any evidence for intracellular processing of BMP2b?

9\) In their test of model 4, \"Shuttling\": Although the data in Figure 5D does not fit the predicted deflection for shuttling, overall BMP diffusion in [Video 10](#video10){ref-type="video"} (with the Chordin clone) seems more pronounced than in [Video 9](#video9){ref-type="video"} (control clone). Instead of comparing diffusion of BMP to the right of the clone (towards the Chordin clone) to diffusion coefficients obtained from other embryos, have the authors compared diffusion on the right to BMP diffusion left of the clone (i.e. away from the Chordin clone in the same embryo)?

10\) The paper contains important data that are of wide interest, but it is somewhat incomplete because it does not experimentally address Sizzled and ADMP. For example the self-organizing model (subsection "Simulations of previous models") implies that these proteins have a 25x higher diffusion coefficient than BMP and Chordin. This seems unlikely, because secreted GFP only seems to have a diffusion coefficient that is \~4-6x higher than Chordin.

11\) The comparison to Nodal-Lefty is misleading. Lefty has a more than 10x higher diffusion coefficient than Nodal, is much more diffusive than Chordin and is induced by Nodal.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Dynamics of BMP signaling and distribution during zebrafish dorsal-ventral patterning\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Didier Stainier (Senior Editor), a Reviewing Editor, and two reviewers.

The reviewers agree that the manuscript has been improved, but there remain some issues that need to be addressed before acceptance. The reviewers\' concerns are outlined below:

1\) It is striking that the authors\' conclusions have changed dramatically in the revised manuscript. Notably, the main conclusion in the initial submission now turns out to be wrong (\"The inhibitor Chordin is required to establish peak levels of BMP signaling without modulating the diffusivity of BMP2b, challenging shuttling models and providing experimental support for classical reaction-diffusion models of patterning.\"). Instead, the authors now prefer a graded source-sink model, rather than the self-organising reaction-diffusion model that they preferred in the previous version. Although the current version of the manuscript is improved, the change in conclusions makes one wonder how firm the current model is. It might therefore be wise to revise the paper to make it more data-driven (since the data are convincing and useful) rather than model-driven, and thus leave open the possibility for refined models in the future. Could the authors please revise the presentation of their manuscript accordingly? The emphasis throughout should be on the value of the experimental measurements, rather than on the models, although it is of course appropriate to provide discussion on how well their data fit with particular models.

2\) The authors\' new results show uniform Chordin-sfGFP distribution through the embryo ([Figure 3---figure supplement 1H](#fig3s1){ref-type="fig"}). These results, together with mutant rescue described in the previous reports, suggest that Chordin does not have to be a localised source or sink, since a third of mutant embryos can develop (some even to adulthood) with uniform Chordin. The authors also show that their bmp2b mRNA injections can rescue swirl/bmp2b-/- mutants and express BMP2b-sfGFP protein through the embryo. So, BMP protein does not have to arise from a ventral source either and the rescued mutants can develop with BMP everywhere. The source-sink models are therefore not consistent with these in vivo observations. Altogether, considering the absence of gradient simulation with uniform Chordin, the disconnect between their current model to protein distribution and mutant rescue, and that the models change as additional parameters become available, the graded source-sink model that the authors now prefer cannot be considered conclusive. The authors should therefore discuss the caveats of their current model in light of these observations.

3\) Since the authors could not measure ADMP diffusion, did the authors test a range of values in their simulations (instead of making the assumption that ADMP has similar diffusivity to Sizzled)?

10.7554/eLife.25861.025

Author response

> Essential revisions:
>
> 1\) The authors present four models for the mechanism by which BMP and Chordin pattern the dorsal-ventral axis, but it is not convincing that these fully represent the current understanding in the field. For example, there are also source-sink models that need to be considered.

This is an excellent point. We have now included the source-sink model as Model 1 and updated the models with more realistic initial conditions to reflect the non-uniform distribution of *bmp2b* mRNA during early zebrafish development. After a careful assessment of the new data, Model 1 is most consistent with all of our measurements.

> 2\) Of the three major conclusions (Discussion, third paragraph), conclusion 1 (Chordin generates signaling peak; reaction-diffusion explains DV patterning) is not convincing, conclusion 2 (BMP does diffuse) is unsurprising, but conclusion 3 (Chordin is more diffusive than BMP) is well supported. In addition, an important fourth conclusion (Chordin does not affect BMP diffusion) should be added.

We have added this important fourth conclusion to the manuscript as suggested. Regarding conclusion 1, please see point 3 below.

> 3\) Absolute signaling levels are difficult to measure and compare. How sure are the authors that in the absence of *chordin* BMP signaling activity is lower on the ventral side?

The reviewers correctly point out challenges associated with the comparison of absolute fluorescence levels. To minimize artifacts, we took the following precautions: 1) mutant and wild type embryos ([Figure 2F-H](#fig2){ref-type="fig"}) were siblings that were fertilized and fixed on the same day, 2) all embryos were processed for immunofluorescence simultaneously using the same reagents, 3) images were acquired in a single imaging session, and 4) gradient quantification was performed before genotypes were established.

To determine whether in the absence of *chordin* BMP signaling activity is lower on the ventral side, we performed an unpaired two-tailed t-test and found that the data sets were not statistically significantly different (p \> 0.05 throughout the ventral side, see new [Figure 2H](#fig2){ref-type="fig"}). We therefore reassessed pSmad1/5/9 immunostainings in a larger number of wild type (n=7) and *chordin* mutants (n=10) and found no consistent statistically significant difference in BMP signaling activity on the ventral side between wild type and *chordin* mutants in any experiment (Figure 2FH). We have adjusted the text and figures accordingly.

> 4\) Previous work has shown that *chordin* mRNA injections at the 1-cell stage rescue zebrafish chordino mutants (Schulte-Merker et al., 1997). Moreover, this brief exposure to uniform Chordin in early embryos is sufficient to generate a normal axial skeleton and fins in rescued mutants, and to grow to adulthood (Fisher and Halpern, 1999). These in vivo observations (of rescue with uniform *chordin* at early stages) contrast with three theoretical models (Pure inhibition, Long-range accumulation and feedback, Shuttling), which presume a localized Chordin source and point towards the self-organizing system in model \#2. It would therefore be valuable for the authors to computationally model how the BMP gradient forms in rescued chordino mutants using parameters that generate uniform Chordin in early embryos. e.g., instead of the assumed/theoretical values in subsections "Simulations of previous models" and "Shuttling simulations of adjacent BMP and Chordin clones shown in Figure 5", they could test constant and uniform Chordin from dorsal\>ventral. Varying the exposure time to uniform Chordin in the simulations would also be informative, i.e., uniform Chordin at early stages vs. uniform early and then localised at the onset of gastrulation, etc.

Both points 4 and 5 are extremely interesting ideas that could be studied in the future, but we feel that this analysis is beyond the scope of the paper. We agree that it would be highly valuable to reveal the mechanism by which uniformly provided Chordin can rescue development in *chordin* mutants. Gradient simulations with varying levels of ectopically provided Chordin are feasible, but in the absence of quantitative pSmad1/5/9 data in rescued embryos, such simulations would be at best speculative if not misleading for the field given the almost infinite number of possible Chordin concentrations that could be tested (see point 5 for details). We have therefore decided not to include these simulations in the manuscript.

> 5\) To complement their analysis of bmp/swirl mutants (rescued with bmp2b RNA injections), the authors could experimentally determine by live imaging how the BMP2b-sfGFP gradient forms in chordino mutant embryos upon rescue with *chordin* RNA injections at the 1-cell stage. Alternatively, measurement of P-Smad levels (as in Figure 1B and Figure 2F) could be sufficient to demonstrate how BMP activity is affected by uniform Chordin.

Although it is an excellent suggestion, the first experiment -- imaging BMP2b-sfGFP gradient formation in rescued *chordin* mutants -- requires BMP2b-sfGFP transgenic lines. However, homologous recombination-mediated large genome modifications are notoriously inefficient in zebrafish, and we have not yet obtained these lines.

To address the second experiment suggestion -- measuring pSmad in rescued *chordin* mutants -- we first injected *chordin* morphant embryos with Chordin-sfGFP. The *chordin* morpholino is well characterized, highly efficient with minimal off-target effects and toxicity, and targets the 5'UTR of *chordin,* leaving the synthetic Chordin-sfGFP unaffected.However, we observed highly variable rescue of morphants, similar to *chordin* mutant rescue experiments in Fisher and Halpern 1999 (\~1/3 show some rescue, \~1/3 are ventralized, and \~1/3 are dorsalized at 24 hpf). It would be useful to measure the pSmad1/5/9 distributions in fully rescued embryos at shield stage, but since it is not clear what phenotype the fixed embryos would have displayed later at around 24 hpf given the rescue variability, it is challenging to establish a clear link between Chordin distributions, pSmad1/5/9 gradients, and phenotypic rescue. It might be possible to establish a correlation by analyzing large numbers of embryos (i.e., hundreds), but this large-scale approach is incompatible with our low-throughput quantitative immunostaining measurements of pSmad1/5/9 distributions. We have generated light sheet images of pSmad1/5/9 and ChordinsfGFP in *chordin* morphants, but we chose not to include this inconclusive data in our study given the conceptual problems with data interpretation outlined above.

> 6\) Figure 3: Is BMP2b-sfGFP / Chordin-sfGFP protein expression initially uniform in the injected embryos at late blastula/early gastrula stages (before transplantations to host embryos)? The authors should show this.

We now show in [Figure 3---figure supplement 1F-H](#fig3s1){ref-type="fig"} that Chordin-sfGFP is distributed nearly uniformly, whereas BMP2b-sfGFP distribution tends to be regionally biased in donor embryos, likely due to injection inhomogeneities combined with the lower diffusivity of BMP2b-sfGFP. But even with non-uniform expression across the donor embryo, our conclusions would remain unaffected since small clones of cells transplanted from donors to hosts likely provide a constant relative flux of protein irrespective of the absolute protein concentration or distribution in the donor.

> 7\) Results, sixth paragraph: In addition to differences in stability or diffusivity, the production rates of the two proteins could also be different. In Figure 4A+B, it seems that Chordin is detected slightly later than BMP2b. The authors should discuss this.

The production rates could indeed be different, and this would affect the amplitude of the gradients but not their shape or range (Wartlick et al. 2009). In [Figure 3F-I](#fig3){ref-type="fig"} we therefore normalized the gradients to the concentration at the source boundary, i.e. gradient amplitude, to highlight the kinetics of gradient shape evolution over time. We now include an additional clarification in the Materials and methods (light sheet microscopy section): "After subtracting this value from the experimental intensity profiles, the data was normalized to the value closest to the clonal source boundary. This approach allows for the comparison of the relative gradient range, which is independent of constant production rates. We assume constant production rates over the relatively short time scales of observation (≈ 80 min)".

The experiment in [Figure 4A+B](#fig4){ref-type="fig"} does not contain information about production rates. For technical reasons, the experiments for Chordin-Dendra2 were on average started slightly later after photoconversion than the experiments for BMP2b-Dendra2, resulting in the slight time shift between the curves.

> 8\) Figure 3---figure supplement 1C: There is a substantial low molecular weight band in the cellular fraction corresponding to cleaved BMP2 (green asterisk in the extracellular enriched fraction) -- why is this detected in the cellular fraction? Is there any evidence for intracellular processing of BMP2b?

Our centrifugation method does not fully separate extracellular and cellular fractions, and some of the supernatant (extracellular enriched fraction) remains with the pellet (cellular fraction), which could explain residual mature BMP2b in the cellular fraction. Moreover, it is likely that some BMP2b molecules remain bound to extracellular matrix components associated with the cellular fraction. Binding interactions with immobile membrane-associated molecules could be relevant and might explain the differences between the hindered/global and the free/local diffusion coefficient of BMP2b ([Figure 4E+F](#fig4){ref-type="fig"}, Müller et al. 2013).

Regarding the intracellular processing of BMP2b, there is a debate in the field about whether TGFβ superfamily ligands are intracellularly or extracellularly cleaved (reviewed in Constam 2014). There is evidence that some BMPs are cleaved intracellularly (Degnin et al., 2004), but processing may vary between different BMP ligands (Fritsch et al. 2012).

> 9\) In their test of model 4, \"Shuttling\": Although the data in Figure 5D does not fit the predicted deflection for shuttling, overall BMP diffusion in [Video 10](#video10){ref-type="video"} (with the Chordin clone) seems more pronounced than in [Video 9](#video9){ref-type="video"} (control clone). Instead of comparing diffusion of BMP to the right of the clone (towards the Chordin clone) to diffusion coefficients obtained from other embryos, have the authors compared diffusion on the right to BMP diffusion left of the clone (i.e. away from the Chordin clone in the same embryo)?

We did not measure diffusivity in embryos that received BMP2b-sfGFP or Chordin-sfGFP-expressing clones. Instead, to specifically address whether Chordin affects BMP2b diffusivity, we performed FRAP in embryos uniformly overexpressing BMP2b-sfGFP only, and in embryos uniformly overexpressing both BMP2b-sfGFP and Chordin ([Figure 4G](#fig4){ref-type="fig"}). These relatively straightforward experiments demonstrated a non-significant effect of Chordin on BMP diffusivity. Measuring BMP diffusivity in embryos receiving transplanted clones is more complicated and would require more inferences than our FRAP experiments. For example, we would have to infer Chordin concentration as a function of distance from the Chordin clone. We therefore argue that our FRAP experiments are a cleaner and more robust methodology to address this question.

We failed to observe consistent differences in BMP2b-sfGFP distribution in clonal transplantation experiments in the presence or absence of Chordin-secreting clones. We now provide additional videos of BMP2b gradient formation to clarify this point ([Videos 9](#video9){ref-type="video"} and [10](#video10){ref-type="video"}).

> 10\) The paper contains important data that are of wide interest, but it is somewhat incomplete because it does not experimentally address Sizzled and ADMP. For example the self-organizing model (subsection "Simulations of previous models") implies that these proteins have a 25x higher diffusion coefficient than BMP and Chordin. This seems unlikely, because secreted GFP only seems to have a diffusion coefficient that is \~4-6x higher than Chordin.

We thank the reviewers for raising this important point. We have extended our biophysical analysis to include Sizzled and now provide a new figure ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) dedicated to the characterization of Sizzled diffusion and its role in BMP signal gradient formation. We also attempted to do the same for ADMP; unfortunately, although we generated three different ADMP fusion proteins (sfGFP inserted 2, 5, and 11 amino acids downstream of the Furin cleavage site with different linkers), we did not succeed in generating a construct that had similar activity as untagged ADMP. We therefore do not include a biophysical characterization of ADMP in this paper.

We found that Sizzled is slightly more diffusive than BMP, but not by a factor of 25 as correctly speculated by the reviewers. We additionally simulated the models (Models 3 and 4) that depend on ADMP and Sizzled for BMP signal gradient formation using our Sizzled FRAP measurements. While Model 3 can form dorsal-ventral gradients with these realistic values, the gradient formation kinetics are not consistent with our measurements ([Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}). Strikingly, Model 4 fails to form any gradient with the diffusion coefficient ratios that we measured (and assuming an ADMP diffusivity similar to that of Sizzled, [Figure 4---figure supplement 1G](#fig4s1){ref-type="fig"}), showing that the model in its current form cannot accurately account for the kinetics of dorsal-ventral patterning.

> 11\) The comparison to Nodal-Lefty is misleading. Lefty has a more than 10x higher diffusion coefficient than Nodal, is much more diffusive than Chordin and is induced by Nodal.

We removed this section from the manuscript.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The reviewers agree that the manuscript has been improved, but there remain some issues that need to be addressed before acceptance. The reviewers\' concerns are outlined below:
>
> 1\) It is striking that the authors\' conclusions have changed dramatically in the revised manuscript. Notably, the main conclusion in the initial submission now turns out to be wrong (\"The inhibitor Chordin is required to establish peak levels of BMP signaling without modulating the diffusivity of BMP2b, challenging shuttling models and providing experimental support for classical reaction-diffusion models of patterning.\"). Instead, the authors now prefer a graded source-sink model, rather than the self-organising reaction-diffusion model that they preferred in the previous version. Although the current version of the manuscript is improved, the change in conclusions makes one wonder how firm the current model is. It might therefore be wise to revise the paper to make it more data-driven (since the data are convincing and useful) rather than model-driven, and thus leave open the possibility for refined models in the future. Could the authors please revise the presentation of their manuscript accordingly? The emphasis throughout should be on the value of the experimental measurements, rather than on the models, although it is of course appropriate to provide discussion on how well their data fit with particular models.

The goal of our study was to test current BMP/Chordin-mediated dorsal-ventral patterning models by experimentally assessing as many of their predictions as possible. This unbiased approach allowed us to rule out some models, while providing support for others. Based on the reviewers' input, we tested an additional model, performed new experiments and simulations, acquired further information about the key players in this system, and performed rigorous statistical tests on all of our data to strengthen the conclusions of the paper. This resulted in new experimental findings that were inconsistent with the models that we previously tested (Models 2-5) but that were consistent with the additional model suggested by the reviewers (Model 1). We agree that this model will likely require refinement in the future as more data becomes available, and have now added a more extensive discussion of caveats and unanswered questions regarding the mechanisms of BMP gradient formation as suggested.

> 2\) The authors\' new results show uniform Chordin-sfGFP distribution through the embryo ([Figure 3---figure supplement 1H](#fig3s1){ref-type="fig"}). These results, together with mutant rescue described in the previous reports, suggest that Chordin does not have to be a localised source or sink, since a third of mutant embryos can develop (some even to adulthood) with uniform Chordin. The authors also show that their bmp2b mRNA injections can rescue swirl/bmp2b-/- mutants and express BMP2b-sfGFP protein through the embryo. So, BMP protein does not have to arise from a ventral source either and the rescued mutants can develop with BMP everywhere. The source-sink models are therefore not consistent with these in vivo observations. Altogether, considering the absence of gradient simulation with uniform Chordin, the disconnect between their current model to protein distribution and mutant rescue, and that the models change as additional parameters become available, the graded source-sink model that the authors now prefer cannot be considered conclusive. The authors should therefore discuss the caveats of their current model in light of these observations.

Based on the rescue of mutants with ectopic BMP or Chordin, it is possible that normal patterning could occur as long as one component of the system is localized (i.e. ventrally biased *bmp* expression with uniform Chordin, or dorsally biased *chordin* expression with uniform BMP) leading to a signaling bias. To determine whether the models under investigation are consistent with mutant rescue, it would be highly relevant to assess the pSmad1/5/9 distribution in rescued mutants, and ideally assess the distribution of the ectopic protein as well. This would address some assumptions about rescue: namely, that BMP signaling is correctly recapitulated during early development, and that ectopic protein is actually uniformly distributed. For example, expression of injected mRNA is not always uniform, and the 30% of embryos that are rescued may have an expression bias. We attempted to answer these questions experimentally, but were unable to obtain interpretable results due to technical limitations (see our previous response to the reviewers' comments). Unfortunately, reasonable models cannot currently be developed without measurements of BMP signaling and protein distribution under rescuing conditions. To address these limitations as suggested by the reviewers, our manuscript now includes a discussion about the caveats of the currently best-supported model, including the fact that apparently uniform Chordin/BMP expression can rescue mutants.

> 3\) Since the authors could not measure ADMP diffusion, did the authors test a range of values in their simulations (instead of making the assumption that ADMP has similar diffusivity to Sizzled)?

In the revised manuscript we now provide additional simulations of Models 3 and 4 using six biologically plausible ADMP diffusion coefficients spanning three orders of magnitude. None of the tested conditions produce reasonable dorsal-ventral BMP signaling gradients when the diffusivities of BMP, Chordin, and Sizzled are constrained with the experimentally measured values.

[^1]: These authors contributed equally to this work.
